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THE EFFECT OF BRCA GENE TESTING ON FAMILY RELATIONSHIPS:  
A THEMATIC ANALYSIS OF QUALITATIVE INTERVIEWS 
 
Heather Ann Douglas, M.S. 
University of Pittsburgh, 2008
 
Individuals with a personal or family history of cancer can pursue testing for mutations in 
BRCA1 and BRCA2, breast and ovarian cancer susceptibility genes, in order to help them make 
decisions about cancer risk-reducing surgeries and other management options.  However, this 
genetic testing can also have emotional consequences, not only for the tested individual but also 
for his or her relatives since testing can provide risk information for them as well.  Thus, this 
study investigated the impact of BRCA testing on family dynamics and family relationships.  A 
qualitative research design was employed, in which a secondary analysis was conducted on 
interview transcripts.  In the initial study, two open-ended, tape-recorded interviews were 
performed using grounded theory methodology with each of 12 participants approximately three 
years apart.  All participants had tested positive for a mutation in either BRCA1 or BRCA2.  
Thematic analysis of interview transcripts was conducted in the current secondary analysis to 
characterize family relationships after BRCA testing.  Three main themes were identified:  1. 
That the first in the family to have testing or seek genetic counseling takes on a special family 
role that can be difficult for them;  2. That discussions in the family, especially those associated 
with BRCA testing, often change after genetic testing; and  3. That individuals may feel more or 
less connected to certain family members after genetic testing has occurred in the family.  These 
changes in family dynamics seem to depend on the family history of cancer, prior relationships 
within the family, emotional coping strategies of relatives, value placed on particular 
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communication patterns, and sharing or not sharing the family’s BRCA mutation.  The results of 
this study highlight the profound changes in family life that can occur after BRCA testing.  
Health professionals can use the insight they gain from this study in their management of 
patients considering BRCA testing.  This work also has public health relevance since it describes 
how genetic testing for susceptibility to a common disease can influence family dynamics.  Such 
an understanding will be important as the genetic basis of common disease becomes better 
understood and tests for additional susceptibility genes become available. 
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1.0  INTRODUCTION 
In the 1990s, the discovery of the BRCA genes offered an explanation for the clustering of 
ovarian cancer and early onset breast cancer in some families.  In these families, it was found 
that individuals who inherited a mutated copy of a BRCA gene had a lifetime risk of cancer much 
higher than that of the general population, while those who did not inherit a gene mutation had 
no elevated risk (Ford et al., 1994; The Breast Cancer Linkage Consortium, 1999). 
Next came the opportunity for members of kindreds suspected to have a BRCA mutation 
to undergo genetic testing to detect a mutation.  Individuals found to have a mutation would then 
know that cancer was likely in their future and could choose surgeries, like bilateral mastectomy 
or oophorectomy, to reduce their risk or could undergo frequent screening in attempt to detect 
cancer in early stages (NCCN Clinical Practice Guidelines).  Individuals for whom no mutation 
was detected could be assured that they did not have an increased chance of cancer, so long as 
testing had confirmed that their family members with cancer did carry an identifiable BRCA 
mutation (NCCN Clinical Practice Guidelines).   
Since early on in the gene discovery process, it had been recognized that this type of 
testing has the potential for serious psychological consequences (Bredart et al., 1998).  To 
address this, typically BRCA testing is preceded by genetic counseling that includes a discussion 
of such consequences.  Also, several studies have investigated the psychosocial effects of BRCA 
testing.  However, very few have focused on how BRCA testing can impact the emotional 
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relationships among family members.  This is of concern since BRCA testing can provide cancer 
risk information not only for the tested individual but also for their relatives.   
Thus, the goal of this study was to investigate how genetic testing for BRCA impacts 
family dynamics and the relationships between family members.  To fulfill this goal, a 
qualitative thematic analysis was undertaken, in which interviews with individuals who had 
BRCA testing were analyzed.  Themes relating to the research goal were identified and will be 
presented and discussed in this paper. 
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2.0  BACKGROUND AND SIGNIFICANCE 
2.1 HEREDITARY BREAST/OVARIAN CANCER (HBOC) AND BRCA GENE 
MUTATIONS 
It has long been suspected that the breast and ovarian cancer in some families has a hereditary 
basis (see Lynch et al. (1979) for a description of various hereditary cancer syndromes and their 
management recommendations over 25 years ago).  The breast cancer in these families 
commonly occurs before menopause, often in close relatives and in several generations of the 
family (Thull and Vogel, 2004).  These families also sometimes include individuals diagnosed 
with ovarian cancer, bilateral breast cancer, or both breast and ovarian cancer, as well as men 
diagnosed with breast cancer (Thull and Vogel, 2004).  Cancer risk in these kindreds thus far 
outweighs that of the general population.   
In the mid-1990s, the discovery of two genes, BRCA1 and BRCA2 (i.e. BRCA1/2 or 
BRCA for simplicity), provided an explanation for the hereditary nature of the cancer for many of 
these families.  Women carrying a mutation in BRCA1 or BRCA2 have a 50-87% risk of 
developing breast cancer by age 70 (Domchek et al., 2003; Ford et al., 1998), up to a 27-44% 
risk of developing ovarian cancer (Domchek et al., 2003; Ford et al., 1998), and an elevated risk 
of a second cancer (Berliner et al., 2007).  They also have smaller risks for other types of cancer 
(Thull and Vogel, 2004).  Male mutation carriers have a 20-30% risk of prostate cancer (The 
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Breast Cancer Linkage Consortium, 1999), a 5-10% risk of breast cancer (Brose et al., 2002), 
and smaller risks for other types of cancer (Thull and Vogel, 2004).  The elevated cancer 
susceptibility has an autosomal dominant mode of inheritance, meaning that both men and 
women can carry the BRCA mutation and both have a 50% chance of passing on the mutation to 
each of their offspring, whether it be a son or a daughter.  The cancer risks and inheritance 
pattern explain why there is usually a cancer history in most generations of the family, with 
females more likely to be affected than males.  
Testing for mutations in BRCA1 and BRCA2 is available and has a sensitivity of 
approximately 85% (Myriad Genetics).  Typically, the best family member to test first is one 
who has had a cancer diagnosis (especially breast cancer at a young age or ovarian cancer), since 
she is the most likely to have a detectable mutation if one is present.  If a mutation is not found, 
the result is said to be ‘inconclusive’ since a mutation could still be present but undetected.  If a 
mutation is found in the first tested individual in the family, it is said to be a ‘conclusive’ and 
‘positive’ result, and at-risk family members can be tested for that specific mutation.  Family 
members can either receive a conclusive positive result, when they are found to have the 
mutation, or a conclusive negative result, when they are not found to have the mutation. 
Female mutation carriers are offered (NCCN Clinical Practice Guidelines): 
1. Aggressive screening including breast imaging and ovarian screening, 
to detect cancer in early stages,  
2. Medications such as Tamoxifen, Raloxifene, and oral contraceptives, 
to reduce the risk of cancer, 
3. Surgeries such as bilateral mastectomy and salpingo-oophorectomy to 
reduce the risk of cancer, and 
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4.   Screening for other types of cancer as indicated by the family history. 
Male mutation carriers are offered (NCCN Clinical Practice Guidelines): 
1. Breast exams and mammography if deemed necessary, 
2. Early prostate screening, and 
3. Screening for other types of cancer as indicated by the family history. 
It is estimated that 1 in 800 people in the general population carry a BRCA mutation 
(Strewing et al., 1997).  However, this rate varies significantly among ethnic groups.  One 
notable group is the Ashkenazi Jewish population, in which the estimated carrier frequency is 1 
in 40 individuals (Tonin et al., 1996).         
2.2 RISK PERCEPTION AND FAMILY RELATIONSHIPS IN THE CONTEXT OF 
HBOC FAMILY HISTORY 
Individuals considering genetic testing for a BRCA mutation have often had their lives colored by 
cancer.  Whether or not they themselves have been diagnosed, many have watched their loved 
ones undergo difficult treatments or die from the disease.  Accordingly, these individuals can 
carry a heavy emotional burden related to their family’s cancer history (Foster et al., 2002).  
Additionally, coping mechanisms and relationships in adulthood may be shaped by past 
experiences, such as having to care for a sick family member or losing a parent to cancer during 
the formative childhood or teenage years (Foster et al., 2002, Kenen et al., 2003a).  Thus, it is 
important to consider how a strong family history of cancer could influence the perceptions and 
decision-making of women considering BRCA testing. 
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2.2.1 Perception of cancer risk in the context of HBOC family experience 
To date, most research about risk perception has been performed for women due to the greater 
cancer risks in female family members.  The findings will be reviewed here. 
Generally, women in families with a strong cancer history either seem to have ‘always 
known’ that cancer runs in the family, or have gradually realized this as more and more family 
members were diagnosed (Forrest et al., 2003).  Some women seem to have come to this 
realization by comparing their families to ‘the norm’ and reasoning that the excess number of 
cancer diagnoses compared to a normal family meant that there was something ‘in the family’ 
(Foster et al., 2002).  Women from a family with several generations known to have had cancer 
generally find it easier to understand where the cancer comes from than women from a family in 
which the known cancer cases are in the current generation only (Foster et al., 2002).  Usually, 
girls or women who have a strong family history of breast and/or ovarian cancer are aware that 
they could follow the family pattern and get cancer as well (Kenen et al., 2003a; Hallowell, 
1999; Forrest et al., 2003; Foster et al., 2002; Kenen et al., 2003b; Raveis and Pretter, 2005).   
However, their perceptions of their own risk are subject to influence by the ‘stories’ 
about the cancer in the family (Kenen et al., 2003b).  These stories seem to pass throughout the 
generations, becoming legacies whose content becomes ingrained in every new generation 
(Werner-Lin 2007) and is used to determine the risk of cancer for each individual in the family 
(Werner-Lin, 2007).  Many of these stories are based on misconceptions, misunderstandings or 
secrets (Kenen et al., 2003b).  For example, several studies have noted that resemblance to a 
relative, physically or behaviorally, is sometimes used by these families to predict whether or not 
an individual will get cancer (Blandy et al., 2003; Werner-Lin, 2007).  For instance, one research 
participant in the Blandy et al. study (2003) stated, “In my mother’s family, all small girls with 
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curly hair develop a cancer, while the others with straight hair do not.”  This misconception may 
stem from the general public’s perception of inheritance as a collection of characteristics that is 
joined together and passed from generation to generation (Kenen et al., 2003b).  Other family 
stories may involve missing elements that were accidentally overlooked by relatives (Kenen et 
al., 2003b) or that were deliberately hidden, often generations ago, due to the stigma associated 
with cancer at that time (Kenen et al., 2003b). 
The perceived saliency of personal risk seems to be higher among women whose 
relatives did not survive their cancer, women who had a mother or sister with cancer, or women 
who have a relative recently diagnosed (Kenen et al., 2003a; Foster et al., 2002).  Raveis and 
Pretter (2005) investigated these trends and found that adult care-giving daughters learning of 
their mother’s breast cancer diagnosis undergo a realization of their personal vulnerability that 
can result in an intense emotional crisis, even though they may have already suspected a 
heritable component to the cancer in their family. 
Saliency of personal risk can also wax or wane with breast or ovarian screening tests or 
with age (Kenen et al., 2003a; Werner-Lin, 2007; Foster et al., 2002).  Interestingly, women at 
risk often identify a ‘danger zone’, a specific age at which they perceive their own cancer risk to 
increase dramatically (Werner-Lin, 2007).  Often, this age is the earliest diagnosis age in the 
extended family or the diagnosis age of a close relative (Foster et al., 2002).  Sometimes, after a 
family member has passed this perceived ‘danger zone’ without getting cancer, she feels less at 
risk (Foster et al., 2002). 
Importantly, family stories based on misconceptions or secrecy, or danger zones 
determining the saliency of risk, can conflict with the scientific information presented by a 
genetic counselor.  Information presented in the genetics consult that corresponds with the family 
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stories is fairly likely to be retained (Foster et al., 2002), however, when the scientific 
information conflicts with the family stories, the counselee often deems the information 
inapplicable to their particular family and instead defaults to their family history and prior family 
beliefs (Foster et al., 2002; Werner-Lin, 2007).  Counselees that accept the genetic counselor’s 
information in lieu of their family stories can sometimes meet adverse reactions when presenting 
the new information to family members who prefer to believe the family stories (Kenen et al., 
2003b). 
Kenen et al. (2003b) were interested in more broadly investigating the processes by 
which women with strong family histories of cancer make decisions about their risk in both 
existential and genetic terms and about how to control their risk.  This group found that, relative 
to women with a less severe family history, women who had many cases of cancer in the family 
and those who had a mother or sister die young more often tended to make use of heuristics, 
cognitive shortcuts that help people make decisions without having to consider large volumes of 
new and difficult information.  One heuristic is ‘availability’, in other words instantly recalling 
sad memories of the loss of a loved one, and using the memories to help make a decision.  This 
could be the basis of the salient personal risk perceived by women who lost relatives to cancer.  
Family stories about risk could be used as a heuristic, helping to make decisions on personal risk 
and genetic testing when the alternative is considering the complicated, confusing and new 
information presented in a genetics consult.      
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2.3 DECISIONS ABOUT UPTAKE OF GENETIC TESTING IN THE CONTEXT OF 
THE FAMILY 
When presented with the option of testing for BRCA mutations, it seems that members of such 
families consider numerous factors.  Among these, they consider the implications for not only 
themselves but also for their family members (Foster et al., 2002; Kenen et al., 2003a; Kenen et 
al., 2006; Hallowell, 1999; Goelen et al., 1999).  Taking the lead from Gilligan (1982) who 
studied psychological theory of women, Hallowell (1999) suggests that individuals (especially 
women) considering testing think about implications for their family because they are thinking of 
themselves as ‘selves-in-relation’, defining themselves in terms of their relationships with and 
obligations to their family.  The research that characterizes this idea is presented here.   
Many research participants stated that getting information for family members was an 
important reason to have BRCA testing (Hallowell, 1999; Tercyak et al., 2007; Phelps et al., 
2007; Foster et al., 2004; Daly et al., 2001; Goelen et al., 1999; Foster et al., 2002; Hallowell et 
al., 2003).  Some went a step further and insisted that it was their duty, obligation or 
responsibility to pursue testing (Hallowell et al., 2003; Hallowell, 1999; Kenen et al., 2003a) 
because they perceived that their family members had a right to know their own risk for cancer 
(Hallowell, 1999; Daly et al., 2001).  Research participants sometimes approached testing as a 
chance to ‘do right’ by their families (d’Agincourt-Canning, 2001) or to fulfill their obligations 
to care for other family members (Hallowell et al., 2003), benefiting their families by providing 
information that could allow them to protect themselves from cancer (Goelen et al., 1999; 
d’Agincourt-Canning, 2001). 
 The decision to have testing was also sometimes made to gain information that might 
help them fulfill the obligation they felt to stay alive for their family members (Kenen et al., 
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2003a; Hallowell, 1999; Foster et al., 2002).  Mothers of young children (Kenen et al., 2003a) 
and women whose own mothers had been ill or had passed away when they were children 
(Hallowell, 1999; Foster et al., 2002) especially felt an obligation to survive.  Women who lost 
their mothers at young ages tended to still be haunted by the helplessness they felt while 
watching their ill mothers and wanted to protect their children and loved ones from similar 
experiences (Hallowell, 1999; Foster et al., 2002). 
 Women also tended to feel obligated to have testing if a dying relative had alerted them 
to the hereditary nature of cancer in the family.  They seemed to recognize that these dying 
family members had felt responsible to warn them of this, and so they in turn felt responsible to 
act on this information and to use it to reduce the chance of repeating the cancer histories of their 
relatives (Hallowell, 1999; Kenen et al., 2003b).  
 Therefore, the decision to have genetic testing is often made in the context of a high 
perceived personal risk for cancer but also by placing importance on the implications of genetic 
testing for family members.          
2.4 POST-TESTING REACTIONS OF THE TESTED INDIVIDUAL 
Not surprisingly, after deciding to pursue BRCA testing, individuals tended to react to their test 
result according to its implications for their own risk, management and self-identity (Kenen et 
al., 2003a), but also according to its implications for family members.  The following 
summarizes this latter observation.       
In several studies, parents were clearly still acting as selves-in-relation after receiving 
their test result.  Those identified to have a BRCA mutation often felt upset or guilty because they 
 10 
may have already passed the mutation on to their children (Kenen et al 2003 Nov, d’Agincourt-
Canning, 2001), even though they recognized that passing along the mutation was a chance event 
and not under their control (Speice et al., 2002; Bradbury et al., 2007; d’Agincourt-Canning, 
2001; d’Agincourt-Canning, 2006).  Parents testing negative also considered their result in terms 
of others.  Generally, they felt relieved that they could not have passed the mutation on to their 
children (d’Agincourt-Canning, 2001; d’Agincourt-Canning, 2006).   
Some individuals testing positive saw their result as a confirmation of what they had 
always assumed about the hereditary nature of the cancer in their family.  For these individuals, 
the positive result had very little impact since there was often an underlying expectation of 
cancer in their future (Werner-Lin, 2007; d’Agincourt-Canning, 2006). 
Also, it appears that the prior testing experiences and results of close family members 
like siblings could influence the way an individual perceives his or her own test result.  For 
instance, individuals testing negative sometimes felt guilty if close family members had tested 
positive (d’Agincourt-Canning, 2006), a phenomenon often referred to as ‘survivor guilt’.  To 
learn more about this, Smith et al. (1999) administered questionnaires that measured the test-
related distress for individuals one week after receiving their BRCA test result.  The participants 
were members of several sibships in a Mormon family, the largest known kindred identified to 
have a BRCA1 mutation.  For the males in the family, carrier status on its own was found to have 
little impact on distress level.  However, relative to a noncarrier male, a carrier male had more 
distress if he was the first sibling tested than if all of his siblings (especially sisters) had already 
tested negative.  Furthermore, noncarrier males whose siblings (again, especially sisters) tested 
positive seemed to be more distressed than noncarrier males whose siblings all tested negative.  
These results imply that men might feel distress because their sisters are at risk of cancer due to 
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the existence of the mutation in the sibship.  For women, carrier females experienced more test-
related distress than noncarrier females, as would be expected due to the substantial cancer risks 
that female mutation carriers face.  Interestingly, however, carrier females who had at least some 
siblings that had already also tested positive experienced less distress than carrier females who 
did not have any siblings that had tested positive or who were the first of the sibship to have 
testing.  Although these results should be replicated in a sample that can be generalized, these 
results provide further evidence that individuals having a BRCA test interpret their results in 
terms of others.    
2.5 DISCLOSURE OF THE TEST RESULT TO FAMILY MEMBERS 
Since individuals’ testing choices and interpretations of test results are so intimately enlaced with 
considerations of implications for family members, it is important to ask also what tested 
individuals do with their test results.  What are the reasons for or against informing family of the 
results?  How and when do they choose to do so?  How do they feel about informing them?  
These questions will be addressed in the current section.  But first, a caveat: Most studies about 
disclosures have focused on disclosures of a positive result, however some have extended to 
those who are hypothesizing about disclosures to family members after testing, as well as those 
disclosing the information they learned at a genetic counseling session, with or without having a 
genetic test result.  This section will consider all of these.  To facilitate clarity, individuals who 
were tested and who have the information to tell will be referred to as the ‘tellers’ or the 
‘potential tellers’.  Family members they have told or are considering telling will simply be 
referred to as the ‘family members’ or ‘relatives’. 
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2.5.1 What are the reasons individuals give for wanting to disclose their genetic 
information to their relatives? 
Not surprisingly, the most important and common reason for deciding to disclose genetic 
information to biological family members was that it could be important and useful for their 
family members to know, since it would provide them with information about their own risks 
and options for testing or management (Hughes et al., 2002; MacDonald et al., 2007; McGivern 
et al., 2004; Claes et al., 2003).  As they did when considering whether to pursue testing, some 
individuals stated that their family members had a right to know the genetic information 
(d’Agincourt-Canning, 2001; Green et al., 1997) and that, by disclosing this information, they 
were fulfilling their duty to inform them (d’Agincourt-Canning, 2001; McGivern et al., 2004; 
Claes et al., 2003; Kenen et al., 2003a).  Other reasons for disclosing information to family 
members were that the family member had actively stated an interest in knowing the test result or 
genetic information (Claes et al., 2003) or the family member themselves had already gone to 
genetic counseling or had genetic testing (Claes et al., 2003).  An additional reason was to gain 
support or help in next steps.  For instance, some women disclosed their test result in order to get 
advice and emotional support from family members regarding surveillance and surgical 
decisions (Hughes et al., 2002; McGivern et al., 2004).  This reason was most important when 
women found to carry a mutation disclosed their result to their sisters (Hughes et al., 2002; 
McGivern et al., 2004).  Some individuals chose to disclose their results to certain family 
members, especially partners, so that they could get help in disclosing the result to other family 
members like their children (Goelen et al., 1999; Hallowell et al., 2005a). 
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2.5.1.1 Factors that have been found to increase the likelihood of disclosure 
Several factors have been found to correlate with an increased likelihood of disclosure to 
family members.  Considering them here serves as a start in appreciating what people think about 
when deciding whether to disclose test results and other genetic information to their family.   
Generally, women are more likely to disclose genetic information to their family 
members than are men (Bradbury et al., 2007; Forrest et al., 2003; d’Agincourt-Canning, 2001).  
As well, personal medical history, family history, family structure and communication seem to 
play a role.  Individuals receiving conclusive genetic testing results were found 6.25 times more 
likely to disclose their test result than individuals receiving an inconclusive result (Claes et al., 
2003).  Also, a personal history of cancer or prophylactic mastectomy was found to correlate 
with a higher rate of disclosure to family members (Julian-Reynier et al., 2000; Bradbury et al., 
2007).  Distant relatives were found more likely to receive genetic information in families having 
a greater number of deceased family members, while tellers close to a family member with 
cancer were found less likely to disclose positive results to their own mother (Claes et al., 2003; 
Julian-Reynier et al., 2000).  Additionally, brothers were more likely to be informed if the 
mutation came from the paternal side of the family than if it was passed from the maternal side 
(Patenaude et al., 2006).  As well, fathers appeared more likely to be told if they had a personal 
history of cancer, possibly because the fathers who had cancer were perceived to be more 
interested or open to discussing cancer-related topics (Patenaude et al., 2006).  Indeed, openness 
about cancer in the family in general, as well as family cohesion and support, have been 
associated with higher rates of disclosure (Claes et al., 2003). 
Age of the teller also seems to have an influence.  Younger women were found more 
likely to disclose information to their distant relatives (Claes et al., 2003) and also to their mother 
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(Claes et al., 2003; Julian-Reynier et al., 2000; Patenaude et al., 2006) than are older women.  
Julian-Reynier et al. (2000) suggested that the latter observation might be because older women 
are trying to protect their (typically older) mothers from disturbing information or because they 
do not perceive the information as useful for their mothers.  Patenaude et al. (2006) present a 
similar interpretation, adding that perhaps older parents are thought to be less able to understand 
genetic information.  They also point out that younger women tend to have younger mothers who 
could still be at significant hereditary cancer risk themselves (Patenaude et al., 2006).  Older 
women are more likely to disclose test results to their own children (Julian-Reynier et al., 2000), 
likely because their children are typically older and closer to imminent genetic risk.  
Accordingly, older child age has been directly associated with more disclosures to children 
(Bradbury et al., 2007). 
2.5.2 Barriers or deterrents to disclosing information to relatives 
Several barriers or deterrents make disclosing genetic or testing information to family members 
difficult, sometimes preventing the disclosure process all together.  The following outlines those 
factors identified in studies to date. 
The most commonly found reason for not disclosing results to certain relatives was that 
potential tellers were either out of touch with their relatives or not emotionally close with them 
(Green et al., 1997; Forrest et al., 2003; MacDonald et al., 2007; Daly et al 2001; Hughes et al., 
2002; McGivern et al., 2004; Claes et al., 2003).  This trend was seen more frequently as the 
reason for not informing genetically distant relatives than for close relatives (Claes et al., 2003).  
In fact, many potential tellers did not seem to feel an obligation to inform family members who 
they did not know or who they were not in touch with (d’Agincourt-Canning, 2001; Green et al., 
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1997).  Interestingly, this loss of contact or emotional distance can sometimes be due to the 
difficult family history of cancer, as deaths can cause branches of the family to lose touch with 
each other, family members can distance themselves because of the emotional pain caused by the 
family cancer experience, or family members can have rifts due to matters concerned with care 
of their sick and dying family (Green et al., 1997).   
Potential tellers were also concerned that sharing the information would alarm or upset 
others in the family, especially when a BRCA mutation was identified (Hallowell et al., 2003; 
MacDonald et al., 2007; d’Agincourt-Canning 2001; Green et al., 1997; Daly et al., 2001; 
Hughes et al., 2002; Kenen et al., 2007; Bradbury et al., 2007; Blandy et al., 2003; Hallowell et 
al., 2005a).  As outlined above, individuals pursue testing largely because they feel an obligation 
to provide beneficial information for their family.  However, upon testing positive for a 
mutation, some individuals seem to feel that the disclosure of bad news conflicts with what they 
feel is their obligation to care for their family (Hallowell et al., 2003; Hallowell et al., 2005b; 
Hallowell et al., 2005a; Green et al., 1997).  In weighing the pros and cons of disclosing bad 
news, tellers considered the vulnerability of family members (Hallowell, 1999; Hallowell et al., 
2005b).  Some tellers were able to overcome their concerns and fulfill the duty they felt to 
inform their family members, often by clinging to the hope of scientific progress (Hallowell et 
al., 2003).  Others felt that the potential for disturbing or upsetting their relatives outweighed the 
benefits of disclosing, at least for the time being (Hallowell, 1999; Bradbury et al., 2007; 
Hallowell et al., 2005a; Hughes et al., 2002). 
Other less commonly mentioned barriers or deterrents for disclosures to family members 
included geographic distance (MacDonald et al., 2007; Green et al., 1997), the assumption other 
relatives would disclose the information to family members (Claes et al., 2003), dilemmas 
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between family members about how to best disclose to others (Hallowell et al., 2005a), the 
teller’s lack of confidence in their own communication skills (Daly et al., 2001; MacDonald et 
al., 2007), the fear that the information would be misunderstood by family members (Hughes et 
al., 2002; Hamilton et al., 2005) and thinking the information would not be useful to the family 
member (Forrest et al., 2003; MacDonald et al., 2007; Daly et al., 2001; Claes et al., 2003). 
2.5.3 Who are chosen as recipients of results? 
Typically, tested individuals disclose their results to at least one relative, whether the results are 
positive, negative, or inconclusive (Patenaude et al., 2006; d’Agincourt-Canning, 2001; 
McGivern et al., 2004; Costalas et al., 2003).  In a study by McGivern et al. (2004), 46% of 
mutation carriers informed less than half of their relatives.  In a study by Costalas et al. (2003), 
probands who tested positive for a mutation shared their results with 83.7% of relatives, those 
who tested negative shared the results with 76.9% of relatives, and those who had an 
indeterminate result shared the result with 64.9% of relatives. 
In general, first degree relatives were more likely to be told of test results than more 
distant relatives (Blandy et al., 2003; McGivern et al., 2004; Claes et al., 2003; MacDonald et al., 
2007).  Distant relatives were more likely to be informed of a conclusive test result than an 
inconclusive result (Claes et al., 2003; Hamilton et al., 2005; Hughes et al., 2002). 
Many studies found that sisters were more likely to be told of test results than were 
brothers (Hamilton et al., 2005; McGivern et al., 2004; Claes et al., 2003; MacDonald et al., 
2007).  This could be because of the greater cancer risks in sisters compared to brothers in these 
families, especially if the teller were found to have a mutation.  As well, sisters may be 
preferentially told if they have a closer relationship to the teller than brothers do, especially when 
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discussing a ‘female’ topic like breast or ovarian cancer.  This gender difference in disclosures 
might extend to offspring, as daughters were found more likely to be told than sons in some 
studies (Blandy et al., 2003; Patenaude et al., 2006; MacDonald et al., 2007).  A similar trend 
may be seen in more extended relatives (Claes et al., 2003). 
Regarding disclosures to offspring, Bradbury et al. (2007) noted that the majority of adult 
and late adolescent children were told about their parent’s mutation or the hereditary risk of 
cancer.  Parents were less likely to disclose this information to younger children (Patenaude et 
al., 2006; Bradbury et al., 2007). 
Results are also frequently relayed to a spouse or partner (Julian-Reynier et al., 2000), 
although further comment on this is out of the scope of this review. 
 
2.5.4 The disclosure process 
2.5.4.1 When and how does the disclosure happen? 
The trends characterizing disclosures to family members are varied.  It is important to 
realize that disclosure choices are likely heavily influenced by the expectations, beliefs and 
norms for each family as well as interactions among relatives.  Hamilton et al. (2005) found that 
some participants told their family members shortly after receiving the BRCA test results.  
Hughes et al. (2002) found a similar trend, in which test results were communicated to 25% of 
sisters on the same day as the disclosure session and to 70% of sisters within one week of the 
teller learning their own result.  Female relatives were more likely to be told in person, while 
male relatives were more likely to be told over the phone or indirectly by other relatives 
(McGivern et al., 2004).     
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Disclosures performed later tended to be more carefully thought out (Hamilton et al., 
2005), as individuals appeared to consider a number of factors when deciding when and how to 
disclose their results to family members.     
Firstly, the tested individual needed to decide who would disclose their test results to 
certain family members.  Individuals sometimes relied on certain family members as a liaison 
between them and other branches of the family (d’Agincourt-Canning, 2001).  Within a kinship, 
parents were generally thought to have the primary responsibility to pass on information to their 
own offspring, suggesting ‘vertical’ authority within these families (Forrest et al., 2003; Blandy 
et al., 2003; McGivern et al., 2004).  For instance, a woman receiving a positive test result might 
inform each of her siblings (or siblings-in-law), who would then decide whether to inform their 
own offspring.  People most likely to be placed in these liaison positions included women, even 
if they are not biologically at risk themselves (Hallowell et al., 2005b; d’Agincourt-Canning, 
2001; Forrest et al., 2003), or family members seen to have some authority or special knowledge, 
such as a medical doctor in the family (Blandy et al., 2003).  Studies have found that the help of 
health professionals in actually disclosing information is generally not wanted, however 
counseling or support in preparing to disclose could be useful (Bradbury et al., 2007; Tercyak et 
al., 2007).   
The readiness of the teller was also found to be considered (Hamilton et al., 2005), as 
individuals discovering that they carry a BRCA mutation often required time to adjust to the 
implications for themselves before telling other family members (Bradbury et al., 2007).  As 
well, the readiness of the family member to receive the information was considered, particularly 
when the disclosure could provoke anxiety or stress (Hamilton et al., 2005; Hallowell et al., 
2003).  To assess if the family member was ready, the teller considered the family member’s 
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personality and life situation (Hamilton et al., 2005).  For instance, certain family members could 
be perceived to be particularly vulnerable to receiving the information, especially those relatives 
who are young, unmarried, consequently identified as mutation carriers, or currently battling 
cancer (Bradbury et al., 2007).  In addition, the setting and method of the disclosure is 
considered.  In some cases, wanting to disclose the information in a particular setting was the 
reason for delaying disclosure (Hamilton et al., 2005).  For instance, some individuals chose to 
delay the disclosure until their adult children returned from college or until a family gathering for 
some other reason like a holiday (Bradbury et al., 2007; Green et al., 1997).  It has been 
suggested that one reason for waiting until seeing family members in person is so that the teller 
could integrate the disclosure into the conversation that would be taking place already, or so that 
they could reduce the alarming effect of contacting a more distant relative solely for the purpose 
of telling them about the mutation (Forrest et al., 2003; Green et al., 1997).  Similarly, Green et 
al. (1997) found that some individuals disclosed to distant relatives by including the information 
about the mutation in a regular communication like a Christmas card letter.  Still others decided 
to disclose the mutation and heritable cancer risks to family members, especially children, 
gradually over months or years (Bradbury et al., 2007). 
2.5.4.2 What information is disclosed? 
It is also important to consider what information is included in a disclosure to family 
members and what topics are discussed afterward.  Studies by Hamilton et al. (2005), Kenen et 
al. (2006) and Hallowell et al. (2005a) showed that tellers tended to select what to disclose, 
sometimes omitting or altering information. 
Disclosures sometimes involved downplaying the seriousness of the implications of the 
mutation, also in an effort to prevent anxiety in their relatives (Daly et al., 2001; DudokdeWit et 
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al., 1997).  Studies also show that several misconceptions about mode of inheritance, cancer risks 
or meaning of the test result are included in disclosures (Kenen et al., 2003b; Blandy et al., 2003; 
Claes et al., 2003).  Other topics of discussion with family members were feelings about their 
own and their relatives’ risks (Hughes et al., 2002; McGivern et al., 2004), screening and surgery 
guidelines, risk of a mutation for family members, cost of testing, and insurance discrimination 
(McGivern et al., 2004).   
What is said during a disclosure can depend on the communication with family members 
before and during testing.  Hallowell et al. (2005a) outlined that parents tended to adopt one of 
three communication strategies during this time: complete openness, limited disclosure, or total 
secrecy.  With complete openness, children had been informed about genetic testing and its 
implications before their parent had testing and they were one of the first to learn the result.  
They knew the full extent of the implications of the mutation.  With limited disclosure, parents 
limited what they told their children about the testing process until after receiving the results.  
Thus, the children in these families were not always prepared for the result.  In families with 
total secrecy, the parent’s involvement in testing was kept a guarded secret until after testing was 
through.  Thus, the disclosure was usually a complete surprise for these children.  In choosing 
the communication strategy, the parents in this study seemed to balance their children’s rights to 
know the information with the parental duty to protect their children from potentially needless 
anxiety.   
2.5.5 How do the tellers feel about making the disclosure? 
Making a disclosure can evoke unexpected and intense emotions (Speice et al., 2002).  For 
instance, for some individuals, particularly those who were the first in the family to be identified 
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to have a BRCA mutation, the process of disclosing the mutation to family members is 
burdensome or upsetting (Hallowell et al., 2005b; Costalas et al., 2003).  As eluded to 
previously, one reason is that individuals can feel guilty or burdened for ‘being the bearer of bad 
news’, revealing the existence of a familial BRCA mutation to their family members (Hamilton et 
al., 2005; Kenen et al., 2006; McGivern et al., 2004; d’Agincourt-Canning, 2001), especially 
when the family already had experienced emotional hardship regarding the death of a close 
family member (McGivern et al., 2004).  Also, individuals may feel pressure to educate their 
family members about complicated genetic information that they may not themselves understand 
well (Kenen et al., 2006; DudokdeWit et al., 1997; Costalas et al., 2003).  
2.6 REACTIONS OF FAMILY MEMBERS TO THE DISCLOSURE AND EFFECTS 
ON FAMILY RELATIONSHIPS 
Initial reactions of family members when receiving news of a mutation from the teller are varied 
and undoubtedly motivated largely by emotion.  Both the genetic information and these reactions 
can have a longer-lasting impact on family relationships.  The following will serve as a review of 
reports in the literature that describe initial reactions from family members and effects on family 
relationships.  
Some family members react to the news by feeling shocked, afraid, resentful, sad, guilty, 
angry, or blameful (Speice et al., 2002; Bradbury et al., 2007; Costalas et al., 2003).  Anger or 
resentment could be because of the timing or the way in which information was given (Hallowell 
et al., 2005b) or, for family members preferring not to know, because the disclosure occurred at 
all (DudokdeWit et al., 1997).   Strong emotions could manifest from concern about one’s own 
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cancer risk or a family member’s risk (DudokeWit et al., 1997) or because the grief or tension 
from a past loss of a family member is reactivated with this news (DudokeWit et al., 1997; 
Speice et al., 2002). 
Additionally, some family members either did not seem to understand the significance of 
the result (Bradbury et al., 2007; Costalas et al., 2003; Blandy et al., 2003), seemed to be in 
denial of its significance or were not convinced of the result’s implications (Speice et al., 2002).  
This last reaction was most common when the result was negative, as some relatives, such as 
children of parents testing negative, were still convinced that their health was at stake (Hallowell 
et al., 2005a, 2005b).  Other family members interpreted a positive result not as upsetting but as 
an explanation for the strong family history of cancer (Bradbury et al., 2007).  Likewise, some 
family members paid less attention to the news of the mutation than to a recent cancer diagnosis 
in the family (DudokdeWit et al., 1997). 
In addressing the teller’s genetic risks, it was noted that some relatives did not know what 
to say to them (Kenen et al., 2006) or were overly comforting to the teller (Kenen et al., 2006). 
After learning of the existence of the family’s mutation, some biological relatives 
eventually chose to be tested for the mutation as well.  Blandy et al. (2003) studied the uptake of 
testing in close biological family members.  They found that the average testing participation 
among informed high risk relatives was 15% (29% for first degree relatives and 12% for nieces), 
and that in 37% of families no close relatives requested testing.  In this study, the choice to have 
testing was positively associated with greater family support and better knowledge of the risk of 
genetic transmission by women. 
If family members do not share the same coping style as the teller, he or she can feel 
frustrated or sad (Speice et al., 2002).  This was especially evident when relatives did not seem to 
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want the genetic information or did not want to pursue genetic testing (d’Agincourt-Canning, 
2001; McGivern et al., 2004; Blandy et al., 2003).  Members of the family sometimes started to 
feel isolated from each other, especially if they were not sure how best to communicate with 
each other, or if they felt they were in different life stages (Kenen et al., 2006; Hamilton et al., 
2005; Werner-Lin, 2007; Speice et al., 2002).  For instance, one research participant in Werner-
Lin’s study (2007) tested positive for a BRCA mutation, as did her older sisters; however she felt 
isolated from her sisters because they were all married with children while she was not.  There 
can also be family discord, especially when family members disagree about the implications of 
the mutation for the family (Speice et al., 2002) or about who should be informed (Forrest et al., 
2003). 
On the other hand, having the mutation in the family can have positive effects on some 
family relationships.  For instance, one research participant stated that she had been feeling 
lonely after her breast cancer diagnosis but upon finding that she shared the BRCA gene with her 
family members she felt consoled, because it then became a problem the family could address 
together (Kenen et al., 2006).  d’Agincourt-Canning (2001) found that genetic testing allowed 
her research participants to strengthen interpersonal ties by providing family members with 
valuable information.  The study by Bradbury et al. (2007) on the effect of genetic testing on the 
overall family relationship found that while 65% of individuals reported no change in their 
relationship with their offspring upon disclosure of the test result, 22% reported a strengthening 
of their relationship.  Also, McInerney-Leo et al. (2005) found that perceptions of family 
cohesion increased upon making a testing decision.  Interestingly, in this study family cohesion 
seemed to increase even if the decision was to not pursue testing. 
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In many families there were reportedly no significant changes in overall family 
functioning, relationships, or family conflict (McInerney-Leo et al., 2005; Bradbury et al., 2007; 
Stroup and Smith, 2007).  
Importantly, testing positive for a BRCA mutation can often impact the relationship with 
a spouse, including strengthening or weakening the partnership.  Review of this is beyond the 
scope of this paper. 
2.6.1 How do families talk about having a BRCA mutation? 
One interesting way to assess the effect of BRCA testing on family relationships is to ask about 
conversations in the family regarding the mutation, cancer, cancer risk, or surgeries after a 
genetic testing result has been disclosed.  So far, few studies have focused on this question but 
some preliminary observations have been made.  One research participant relayed that after her 
sisters’ and her cousin’s diagnosis ‘family life became dominated by conversations about 
cancer…consumed with fad cures, drinking gallons of green tea and sprinkling flax seed on the 
children’s breakfast cereal’ (Werner-Lin, 2007).  On the contrary, other families seem to contain 
some family members who felt stigmatized and thus were very resistant to talking about the 
inherited breast/ovarian cancer in the family (Kenen et al., 2007).  This can create ‘areas of 
sensitivity’, further discouraging these conversations (Bradbury et al., 2007), and can cause other 
family members to feel shunned at family events by relatives not as open to discussing it (Speice 
et al., 2002).   
McInerney-Leo et al. (2005) measured the expressiveness within families over time after 
BRCA testing and noted that at 6-9 months after testing there was a trend toward a reduction in 
expressiveness.  They suggested that this trend could reflect an initial tendency to express 
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emotions about the test result to friends or other individuals outside the family rather than to their 
family members, who may be upset and concerned about their own risk or the risk of their 
family. 
2.7 METHODOLOGY OF THE STUDIES OUTLINED ABOVE 
Many of the studies outlined above were quantitative studies, in which trends were discerned by 
analyzing questionnaires that measure specific elements.  While these studies are valuable in 
characterizing some components of the experience of members of hereditary breast/ovarian 
cancer families, they do not allow researchers to discover and characterize issues that researchers 
do not anticipate (Beeson, 1997).  However, a thorough understanding of the full breadth of 
experience is required for health care professionals like genetic counselors to effectively and 
empathetically interact with members of these families.   
Qualitative research, sometimes using open-ended interviews, can provide a way to 
detect unexpected experiences of these families since it is the research participants themselves 
that lead the direction of the study.  Qualitative research is often about exploring meaning; it 
attempts to understand both what people do and why they do it (Beeson, 1997).  Qualitative work 
may also place importance on all observations no matter how deviant from the ‘norm’ they are.  
Thus, qualitative work can be very useful for health care professionals to sensitize themselves to 
the experience of the individuals or families they are meeting with. 
Several qualitative studies have been performed to describe the perception of risk and the 
experiences people have as part of a family with a strong history of breast/ovarian cancer, as 
outlined above (Kenen et al., 2003a; Phelps et al., 2007; Raveis and Pretter, 2005; Werner-Lin, 
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2007; Hallowell, 1999; Foster et al., 2002).  Others have focused more on the testing decisions 
and on family communication of genetic information including disclosures of BRCA test results 
(Green et al., 1997; Hallowell et al., 2003; d’Agincourt-Canning, 2006; d’Agincourt-Canning, 
2001; Forrest et al., 2003; Foster et al., 2002; Goelen et al., 1999; Hallowell et al., 2005a; 
Hallowell et al., 2005b; Hamilton et al., 2005; Kenen et al., 2004).  There have been very few 
qualitative studies performed to date that have focused specifically on the impact that BRCA 
testing has on family relationships.  Notable exceptions are an early case description by 
DudokdeWit et al. (1997) of a family testing for BRCA, and a study by Speice et al. (2002), using 
a family-oriented psychoeducational group for women who tested positive for a BRCA mutation.  
A few other studies investigating general effects or impact of BRCA testing noted some changes 
in family relationships as part of their results (Kenen et al., 2007; Kenen et al., 2006).  
Considering this, there is a paucity of qualitative studies that characterize the impact of BRCA 
testing on families and the relationships between family members. 
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3.0  AIM OF THE STUDY 
The current study served as a secondary data analysis of a qualitative study investigating the 
impact of BRCA testing on family dynamics and the relationships between family members.  
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4.0  METHODS AND PROCEDURES 
The initial study, including recruitment and interviews of participants, was conducted by Dr. 
Rebekah J. Hamilton and was approved by the Institutional Review Board (IRB) (0509094).  
Data from some of these interviews, regarding disclosure of genetic test results to family 
members, have been published previously by Hamilton et al. (2005).  The secondary analysis of 
the interviews, constituting the current study, was approved by the University of Pittsburgh IRB 
(PRO07080253).   
4.1.1 Interviews with research participants 
The qualitative research design conducted in the initial study included open-ended interviews 
with members of families who have confirmed or probable hereditary breast/ovarian cancer 
syndrome.  Grounded theory methodology was employed during the interviewing for that study.  
Grounded theory methods involve simultaneous collection and analysis of data in order to build 
theoretical frameworks that explain the data.  Additional data collection is based on the ongoing 
analysis, helping to further develop the theoretical frameworks (Charmaz, 2000).  The interviews 
used in the current study were thus suitable for a complete grounded theory analysis to be 
performed if desired.  However, a more limited scope was employed using secondary analysis to 
identify themes (see below). 
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Phone or in-person interviews are the more traditional form of data collection for 
qualitative studies using interviewing as part of data collection.  However, recently email 
interviews have been introduced as an appropriate alternative, as outlined by Hamilton and 
Bowers (2006).  Therefore, interviews of participants in the initial study were performed either 
over the phone or by email, depending on the participants’ preferences.  All interviews were 
performed by Dr. Rebekah J. Hamilton.  Of all participants interviewed by Dr. Hamilton, those 
who had participated in two interviews – an initial interview and another approximately three 
years later – were chosen for secondary analysis in the current study. 
4.1.2 Participant recruitment 
Study participants were recruited by posting notices on a hereditary breast/ovarian cancer 
syndrome support website (FORCE: Facing Our Risk of Cancer Empowered:  
www.facingourrisk.org).  All participants gave informed consent prior to being interviewed. 
4.1.3 Transcription 
Telephone interviews were transcribed verbatim from audiotapes to Microsoft Word by a 
professional transcriptionist.  Personal identifiers were removed in accordance with the IRB, and 
participants were given pseudonyms.  Transcripts preserved the participants’ and the 
interviewer’s grammar, unfinished sentences, pauses, and placeholders as best as possible.  
Email interviews did not require transcription so were copied and pasted into Microsoft Word.  
Interview passages that were included in this report were subject to minor revision only when it 
was judged that the revision would not take away from the meaning of the passage but would 
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facilitate easier understanding of the passage by the reader.  Examples of revision include 
correcting spelling and grammar mistakes and removing some of the interviewer’s minor 
contributions to telephone interview transcripts.     
4.1.4 Thematic analysis as the method of secondary analysis 
Secondary analysis in qualitative research is defined by Thorne (1994) as the analysis of data 
either beyond its original intent or in relation to new and extended inquiries.  It is often 
performed by individuals who were not involved in the initial study design or collection of data 
(Thorne, 1994).  The current study is classified as secondary analysis since it represented an 
extended study of the interview transcripts and was performed by an individual not previously 
involved with this study. 
Thematic analysis was chosen as the most appropriate method for the secondary analysis 
of the interview transcripts.  This is a method for identifying, describing, analyzing and reporting 
themes and patterns within data (Braun and Clarke, 2006).  It was chosen because it is a flexible 
technique that can be used to analyze data obtained under a number of qualitative theoretical 
frameworks, including grounded theory (Braun and Clarke, 2006), and because it is relatively 
easy and quick for new qualitative researchers to learn (Braun and Clarke, 2006).  A drawback to 
using thematic analysis is that its methodology is not well-described and thus is open to 
interpretation especially at higher levels of analysis (Braun and Clarke, 2006).  However, it was 
judged that the benefits to using thematic analysis for this study outweighed this drawback. 
Thematic analysis allows for either a rich description of the data set related to a broad 
research question or a detailed description of a particular theme within the data (Braun and 
Clarke, 2006).  In the former scenario, typically the researcher is interested in gaining a cross-
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section of experiences related to their research question, and they use an inductive approach in 
which patterns and themes are linked to the data and are not fundamentally driven by the 
researcher’s prior theories or preconceptions (Braun and Clarke, 2006; Boyatzis, 1998).  In the 
latter, researchers typically are interested in a very specific idea derived from reading the 
literature, from their prior research studies or from their clinic experience.  These researchers 
tend to take a theoretical or deductive approach to their thematic analysis that derives from their 
pre-existing ideas (Braun and Clarke, 2006; Boyatzis, 1998).  All thematic analyses include not 
only a description of the themes identified but also an interpretation of these themes, often in 
relation to previous reports in the literature (Braun and Clarke, 2006).   
 Since few qualitative studies had previously examined the effects of BRCA gene testing 
on family relationships, an inductive thematic analysis approach was chosen so that a cross-
section of family effects related to BRCA gene testing could be explored.  This data-driven 
approach would be of benefit also because it would allow identification of unexpected themes in 
the data (Braun and Clarke, 2006).     
The following outlines the main steps performed during the thematic analysis in the 
current study. 
4.1.4.1 Becoming familiar with data and background literature 
All transcripts were read twice by the author before coding to gain an appreciation of the 
scope of the data set.  Some preliminary notes were made upon reading each transcript.  A 
comprehensive review of the literature, as summarized in the Background and Significance 
section, was also completed prior to coding the transcripts.  This literature review was performed 
to sensitize the author to subtle concepts that may be present in the data but could be missed if 
not introduced to the author prior to coding.  Charmaz (2000) encourages the use of sensitizing 
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concepts such as literature searches and clinical experiences as points of departure from which to 
study the data.  Likewise, Boyatzis (1998) asserts that knowledge relevant to the topic being 
examined is crucial, and that training in the area is also useful, in being ready to see what is in 
the data.  Charmaz (2006a) highlights that when performing inductive qualitative analysis, it is 
important to remember that our prior perspectives represent only one view among many and that 
we must guard against imposing our preconceptions on the data, instead requiring that our 
preconceived ideas each earn their way into the analysis.  The method used to generate codes, as 
outlined in the next section, was critical for preserving the integrity of the data in this way. 
4.1.4.2 Generating initial codes 
Coding is a process that defines what the data are about (Charmaz, 2006a).  The simplest 
definition of a code is a ‘label’ that describes the data (Boyatzis, 1998; Richards and Morse, 
2007).  However, coding is also the first analytic step in thematic analysis, as coding pushes 
researchers to try to understand what their research participants meant when making statements, 
as well as to look at statements in ways that may not have occurred to the participants themselves 
(Charmaz, 2006a).  Codes can ultimately represent links between the data and an idea (Richards 
and Morse, 2007) and can be organized into categories or themes based on their content or 
motivations.  After initial coding, the category or theme, rather than each individual code, 
becomes the focus of attention (Richards and Morse, 2007). 
Initial coding in an inductive thematic analysis is driven by the goal to remain open to all 
possible interpretations.  As Richards and Morse (2007) describe it, initial coding involves 
creating a mixture of descriptive codes and topic codes.  Descriptive coding involves storing 
information known about data items (Richards and Morse, 2007), for example the research 
participant’s age, number and sex of siblings and children, whether they had tested for a BRCA 
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mutation and whether a mutation was found upon testing.  This type of coding is not subject to 
much bias since it focuses on facts.  Topic coding, however, is a far more analytic activity, as 
Richards and Morse (2007) point out here. 
Topic coding…entails creating a category or recognizing one from earlier, reflecting on 
where it belongs among your growing ideas, and reflecting on the data you are referring 
to and on how they fit with the other data coded there. 
   
Due to the potential for complexity in meaning, several topic codes can mark the same passage 
(Richards and Morse, 2007).  Since topic coding is more analytic than descriptive coding, it is 
subject to more bias from the researcher’s background and preconceptions.  To minimize bias, 
the topic codes in the current study were made as descriptive of the participant’s experience or 
thought as possible.  Sometimes, ‘in vivo’ codes, codes using the participants’ own special terms, 
were created to help preserve the meanings of the participants (Charmaz, 2006a).  More abstract 
or interpretative thoughts were recorded throughout the coding process in memos (see below).   
The process of topic coding can be done using several techniques, two of which are 
outlined here briefly.  Firstly, line-by-line coding involves giving at least one code to each 
phrase, line or sentence in the data set.  Charmaz (2006a), a proponent of this method, asserts 
that coding each line challenges the researcher to be critical and analytical about what the 
participant is saying both explicitly and implicitly, rather than merely immersing herself in what 
the participants state are their worldviews.  Secondly, Rennie (2006) suggests that coding 
‘meaning units’ is sometimes more appropriate than line-by-line coding.  He argues that people 
being interviewed wish to make a point, and when they have made it they move on to another.  
Thus, each ‘point’ is essentially a ‘meaning unit’, or an ‘envelope of meaning’ (Rennie, 2006) 
and each can be coded.  While both Charmaz and Rennie provide guidance for coding during a 
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grounded theory analysis, in doing so they may provide insight into coding for the purposes of 
thematic analysis as well.   
For the current study, line-by-line coding was chosen because some participants seemed 
to be distracted and would sometimes flip back and forth unprompted between different topics, 
making meaning unit coding difficult.  As well, a line-by-line approach encouraged attention to 
every detail in the transcript, something to which the researcher responded well.  Therefore, line-
by-line coding of the parts of the transcript that addressed the family was performed.  Many of 
the transcripts also focused on management decisions and sometimes other subjects.  These parts 
of the transcripts were not coded but were read in case they could have an influence on family 
relationships.  If a connection was suspected, it was outlined in a memo.   
Coding was facilitated by several tips made by Charmaz (2006a) and Boyatzis (1998), 
including attempting to stay close to the data, keeping codes short, simple and precise, 
preserving actions in the codes (i.e. using verbs ending in ‘-ing’ whenever possible), moving 
quickly through the data, and not being distracted by personal concerns such as fatigue, sensory 
overload, frustration or confusion.   
Grounded theory typically involves another level of coding performed after initial coding, 
called focused or selective coding (Charmaz, 2000; Charmaz, 2006a).  In this phase, the most 
common, interesting or significant initial codes are used to sift through large amounts of data and 
select and develop only these significant topics (Charmaz, 2000; Charmaz, 2006a).  This type of 
coding is generally more directed and conceptual than initial coding (Charmaz, 2000; Charmaz, 
2006a).  As inductive thematic analysis is a less directed and less theoretical approach to analysis 
than performing a full grounded theory, it was decided that focused coding was unnecessary for 
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this analysis and instead the initial codes would be used to determine and characterize themes 
present in the data (see below). 
In the current study, coding was facilitated by importing interview transcripts from 
Microsoft Word into QSR’s Nudist Vivo (version 7.0.281.0 SP4), a software program that assists 
researchers in coding qualitative transcripts and in organizing the codes into candidate themes. 
4.1.4.3 Memo writing 
It is recommended that researchers write freely and often about their thoughts while 
coding and while identifying and describing themes.  As Charmaz (2006b) says, ‘memos catch 
your thoughts, capture the comparisons and connections you make, and crystallize questions and 
directions for you to pursue.’  Memo writing thus provides a venue to express thoughts about 
individual codes, developing themes, and connections between themes. 
There is no ‘wrong’ way or time to write a memo (Charmaz, 2006b; Richards and Morse, 
2007).  In the current study, memos were written from the onset of reading the interviews, 
throughout the coding process, and throughout the identification and clarification of themes.  
Looking back at earlier memos was useful in recalling each research participant’s story, 
interesting points they discussed, and what the researcher was thinking during each stage of the 
process. 
4.1.4.4 Identifying and characterizing themes 
A theme in qualitative research is defined by Braun and Clarke (2006) as something that 
captures an important aspect of the data in relation to the research question.  Representation of 
the theme across the data set is ideal but not necessary (Braun and Clarke, 2006).   
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In the current study, identification and characterization of themes was a process.  Initial 
ideas about themes were noted early on.  Potential themes were described in memos throughout 
the initial stages of coding.  After coding the interviews of the first few participants, codes were 
organized using the Nudist Vivo software into potential themes or subthemes depending on their 
content or motivation.  Often, codes were classified under several themes.  For each additional 
interview transcript, codes were organized into these preliminary thematic categories.  At a few 
points throughout the analysis the codes were reorganized to better reflect the themes present in 
the data.     
After all interviews were coded and all codes were classified under thematic headings, 
the themes and subthemes characterizing the codes were listed in a memo.  Then, a preliminary 
thematic map was created, consisting of a visual map of each theme and the connections between 
them.  From this, three major themes were selected to be the focus of the current paper.  They 
will be described in the Results section. 
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5.0  RESULTS 
5.1 CHARACTERIZATION OF THE SAMPLE 
The analysis involved 12 participants, all testing positive for either a BRCA1 or BRCA2 
mutation.  These 12 participants came from a total of eight families, since there were two 
families in which three family members participated in the study.  All but one participant were 
female.  Ages ranged from the mid-20s to the late-50s.  Some participants had a personal history 
of cancer.  Most participants were married or partnered, and most had biological children. 
5.2 THEMES IDENTIFIED IN THE ANALYSIS 
The thematic analysis identified several themes reflecting how testing positive for a BRCA 
mutation can impact family relationships.  This paper will focus on three of these themes, since 
they were commonly mentioned and thus easiest to characterize with the available data.  
Additional themes will be listed later in this section.  Importantly, as family relationships can be 
complex, so can the themes that were identified.  Thus, although the three major themes 
described here have some distinct features from one another, they are also related.  An overview 
of the connections between the three themes will be discussed after an explanation of each. 
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5.2.1 Theme # 1: New or changed family roles for the index case 
The first individual in the extended family to pursue genetic counseling or testing is often 
referred to as the ‘index case’ of the family.  After genetic testing, most of the index cases in the 
current study seemed to take on a new role in their families.  Here this new role will be 
characterized.   
5.2.1.1 Obligation to inform family members 
  Firstly, those index cases receiving news of  their  BRCA mutation usually felt  obligated 
to inform relatives.  Interestingly, this obligation was also felt by other participants who fit the 
role of index case in some sense.  For instance, Claire was the first in her family to attend genetic 
counseling, due to her strong family history of breast and ovarian cancer.  She had not been 
diagnosed with cancer so was not the appropriate person to test first in the family.  However, she 
convinced relatives to pursue testing, and she organized a family meeting with the genetic 
counselor to discuss the likelihood of hereditary cancer in their family.  She was also the first in 
the family to learn of the family’s BRCA mutation.  When asked about disclosing these results to 
her family, she clearly indicates the obligation she feels as the index case. 
I was the first person in the family.  I’m kind of the person who opened the can of worms.  
So, um, I felt that responsibility very heavily. 
     
A similar sense of responsibility was expressed by Danielle, whose mother was actually the first 
in the family to have testing, but died only two weeks after learning that she carried a mutation.  
Danielle later had testing and discovered that she also carries the mutation.  Danielle says: 
I feel this huge sense of responsibility to let extended family know to kind of you know, 
if they want to be tested they can be. 
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In this case, after her mother’s death, Danielle seems to have assumed the role of ‘index case by 
proxy’, taking on the task of disclosing the result to her relatives since her mother never had a 
chance to do this before her death.  Interestingly, although this participant wanted her distant 
cousin to know she possibly carried the mutation, she did not feel she had the right to actually 
tell her. 
With my um, like I called my mom’s cousin, who has breast and ovarian cancer and I was 
really worried about that because I didn’t want, I mean we know she has the gene, without 
her being tested, but I was did not feel I had the right to say that and so wanted to tell her 
that my mom tested positive and that you know, I did and that uh, there’s concern, kind of 
thing. 
     
Thus, Danielle served the obligation she felt as the ‘index case by proxy’ to let this relative know 
of the test result without directly stating her assumption that the cousin has the mutation. 
5.2.1.2 Acting on the responsibility to bring news to the family can be burdensome 
for the index case 
Upon feeling this responsibility to inform family members of the BRCA mutation in the 
family, most study participants took the primary role in dispensing the information throughout 
the family.  This role of ‘bringer of news’ was not always easy, however.   
For example, several participants felt upset when disclosing the news of the mutation to 
their family.  Many felt guilty during the disclosure, even though they thought that guilt was an 
irrational feeling.  This sentiment is best expressed by Judy, who was the first in her family to 
have genetic testing, several years after a diagnosis of breast cancer. 
I almost had feelings that I had done something “wrong” and was confessing to them.  
Intellectually I know that is silly, but it was the feeling.  Perhaps it was hard because it 
meant my breast cancer really was more than about me – and was now a factor for the 
whole family.  And it was out of my control!  Who wants to be the bearer of bad news? 
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Interestingly, some index cases appeared to feel guilty even when the news of the family 
mutation was welcomed by family members.  For instance, Monica, who chose to have a 
prophylactic mastectomy upon learning she carried the family BRCA mutation, recalls 
conversations she had with her aunt, the index case in her family, after her aunt sent a letter 
informing her of the mutation. 
 Interviewer: And how was that letter received in the family? 
Monica: Um, funny.  I’ll say by us it was received by my immediate family and my mom 
and my sister and I, very positively and grateful.  My aunt herself…had a little bit of, 
um…you know, guilt at times.  When we’ve gone through it like…‘If I hadn’t found out 
then they wouldn’t have to go through that, you know.’  What I’ve always thought was 
great that we know…And there was a couple times when I was having a hard time, at, the 
email that she wrote me a couple things, and I wouldn’t call it quite this, but like an 
apology, but kind of just overwhelming emotion like, ‘God you’re going through so 
much.  I can’t, kind of like, I can’t believe what I started.  I hope it didn’t open up too 
much.’  And me in response, ‘Oh my God, no.  You know, I wouldn’t, I made the 
decision to follow through with it, I wouldn’t trade it for anything.’ 
 
Thus, the index cases who participated in this study tended to feel a special obligation to 
inform relatives of their mutation, but found that doing so could be burdensome due to the 
enormity of the implications of the news for their family. 
5.2.1.3 Index case as role model 
Getting cancer and testing positive for a BRCA mutation created a different burden for 
another participant, Elise, who was also the first in her family to have testing.  After her cancer 
diagnosis and her positive BRCA test result, she felt pressured to act as a role model to her 
family, especially her younger siblings.   
Interviewer: Can you talk some more about what it was like to be the "first" identified in 
your family and thus the one to tell the news?  Do you think there has been any change in 
your relationships with your parents or siblings because of this? 
Elise:  It sucks to be first.  I feel like I always have to have the answers and be the voice 
of reason.  (I'm the oldest child and have always been maternal towards my brothers and 
sisters).  So even though I'm a basket case to my sweet husband- to my brothers and 
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sisters I feel like I have to be at peace with all of this.  If I'm not, how can I expect them 
to be.  I don't want them to live scared because of this.   
 
She even explains how she communicates with her siblings so that she doesn’t alarm them. 
  
I wanted to be gentle with my brothers and sisters because I know that this type of risk is 
so difficult to deal with at such a young age.  (Yes, the cancer patient was calming 
everyone else down.  Doesn’t that seem backwards.)  
 
In the first passage, this participant suggests that her established role as a maternal big sister 
might have encouraged her to act as a role model to her siblings in this situation.  However, this 
particular participant’s family history may also have provoked such pressure.  Before her own 
breast cancer diagnosis at age 28, she did not know of any cancer history in her parents, aunts, 
uncles or cousins.  Upon investigation after her diagnosis, the family discovered a strong cancer 
history in distant relatives that was consistent with a hereditary cancer syndrome.  When asked if 
it might have been the lack of cancer in close family that is forcing Elise to be a role model, she 
agrees. 
Interviewer:  If you had known there was a "family history" of cancers in your family, do 
you think your response (i.e. feeling guilty) would have been different when the 
mutations were identified?  How so? 
Elise:  I think it would have been different.  I would have had someone else to point to- or 
someone else to relate to.  I feel like I am setting the "standard" here.  I.e., you should 
feel this way when diagnosed, you should feel this way after chemo.  It's all new to my 
family.  If we would have known, it wouldn't have been such a shock.  Everything has 
felt like a big giant snowball picking up speed- maybe if we would have had some idea 
we would have been on more even ground with all of this.  I would definitely not feel like 
I have to be such a role model about this whole thing.  
 
Interestingly, Elise’s mother, Evelyn, acknowledges her daughter’s special role in the family but 
does not suggest that it has been burdensome to her daughter. 
[Elise]’s been amazing because she’s really been the one that has kept this um, almost all 
together and I even wrote her a letter just before her last chemo treatment just telling her 
how proud I was of her because she was the one we all took our cue from.  She was the 
one that was always upbeat, um, very seldom did you see her down…I would just sit 
back in awe and say, this is my child, my child, and look at what she’s doing. 
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Although feeling pressured to be a role model was not common for the index cases in the current 
study, it was an important feeling for this participant and thus worthy of description.  This 
situation also exemplifies that the burden felt by an individual after genetic testing may not be 
recognized by their family members.  Moreover, it appears that her mother is reinforcing her 
daughter’s burdensome behavior. 
5.2.2 Theme # 2:  Genetic testing affects discussions in the family 
The second major theme identified in the study was that a positive BRCA test result commonly 
impacted discussions between family members.  The following outlines several different ways in 
which discussions were influenced in the current study. 
5.2.2.1 Testing facilitates conversations in the family 
For some individuals, receiving the news of a BRCA mutation in the family resulted in 
more talk about cancer, cancer risk, or associated topics like prophylactic surgeries.   
For example, genetic testing served as a catalyst for opening up Naomi’s relationship 
with her father, which had been strained since Naomi lost her mother to breast cancer. 
My dad and I have always had a pretty stilted relationship and a hard time talking about 
my mom – in a lot of ways having the concrete issues of the testing process to discuss 
made the whole issue more approachable.  I also definitely felt his approval and relief 
that I was doing something about the cancer thing, so that has made our relationship 
somewhat more comfortable. 
 
Likewise, Elise feels that the genetic testing she pursued following her cancer diagnosis opened 
up discussion about cancer and genes in her family.  However, for her, these conversations 
sometimes have had a negative effect. 
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My family is no longer as lighthearted as we once were.  Genetic discussions happen all 
the time.  I feel like there is absolutely no escaping this disease…Every time I pick up the 
phone someone else is calling to talk about my breasts.  
 
Importantly, this is the same participant who felt forced to be a role model to her family, as 
described above.  Interestingly, Elise’s sister, Emily, does not perceive that genetic testing has 
fueled family discussions significantly. 
The family doesn't talk about the mutation directly, except when the testing was done. 
Since the cancer is such a big part of our life, we don't really discuss the what-ifs of 
everyone else. 
 
It is possible that the discord between these perceptions could be because Elise, the index case 
and first in the immediate family to get cancer, is likely at the center of most genetic 
conversations in the family while Emily, never diagnosed, may not be so intimately involved in 
such discussions.  Their mother, Evelyn, sees genetic testing as having mostly a positive impact 
on their family discussions. 
Interviewer:  If you had to, if somebody just asked you a general question about, you 
know, what do you think the impact of having these predictive genetic tests in your 
family has been, how would you answer that? 
Evelyn:  I think that all and all it’s been a very positive, um, it’s given us a focus away 
from so much Elise having the cancer and saying OK, this is why Elise had the cancer, 
and again we’ll do what we can do to try and not have it. 
 
Thus, testing positive for a BRCA mutation seems to have the potential to open up discussions 
about cancer and genetics in the family, and this may be welcomed or unwelcome.  An important 
observation is that different members of the same family can perceive the impact on their 
discussions differently. 
Genetic testing for BRCA mutations promoted conversations for family M as well.  
Family M included a nuclear family that was already very close and talked about cancer 
frequently even before genetic testing, due to the strong history of breast cancer on Mike’s, the 
father’s, side of the family. 
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Interviewer:  When you all are together is [cancer] a common topic of conversation or not 
so much anymore or…. 
Mike:  No, it’s real common.  Every single conversation.  It always has been.  Now of 
course it’s much more personal. 
Interviewer:  Now when you say it always has been…before testing what was the 
conversation? 
Mike:  …we didn’t talk about it quite that much. 
 
In this family, genetic testing has encouraged Mike to be more in touch in general with his two 
daughters, who are in their 20s and who both tested positive for the mutation. 
I think of them much more frequently now that um, this kind of news has happened and 
we communicate more regularly than we did before and that’s, we’ve always been very 
close, but I just kind of have this feeling of, of I don’t know, just maybe the time that I 
have with them is, really means a whole lot more to me now. 
 
One of his daughters, Mary, notes a similar change in their relationship, saying: 
And I think it’s definitely, definitely hit my dad a lot harder than I thought it would, even 
though, again we’re very close, but it, it’s hit him in a way that I wasn’t expecting.  I 
think it’s caused him to be um, like I said a little more um attentive to us, he puts the 
extra mile to make sure he has a conversation with us as opposed to like hearing 
conversations through my mom and getting an update on my new job or something 
through my mom.  He calls up sometimes.  I mean, like last week he called my sister at 
7:30 in the morning and said ‘Good morning, I just wanted to say hi and have a good 
day,’ and she was like, ‘What the hell?’ 
 
Thus, for some families, genetic testing can promote discussions not only related to cancer risk 
but general conversations as well.  The reactions to these conversations may be positive or 
negative, and may be shared by family members or not. 
5.2.2.2 Disapproval of topic during family discussion 
In the families in this study, it was quite common that there were at least some relatives 
that did not want to talk about the family BRCA mutation.  They let other family members know 
of their wish in various ways.  An uncommon way was by directly telling them.  Claire 
experienced an example of this. 
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And one niece actually after I had told the family about the results sent message through 
her mother, my sister, that um, I had mentioned it, now once I told about it I could, um, 
basically damn well shut up now.  It was pretty, she doesn’t speak, she wouldn’t say 
damn, she would not use those words, but um, yeah, it was, she was, she was really quite 
adamant that she did not want, and she said something to the effect of ‘I don’t want this 
coming up every time the family gets together.  We don’t need to talk about it.’ 
 
More often, family members used subtle, indirect messages to discourage talk of the mutation.  
For instance, Danielle describes feeling this message from her siblings.  
I mean they never bring it up now, I’m the one who has to bring it up.  That’s you know, 
I don’t think they really want me to, anymore.  There’s certainly a subtle message.  If I 
bring it up they’ll talk about it but there’s definitely a subtle, I guess a picture, ‘this is not 
what we want to talk about.’  And they won’t ever bring it up.  They’ll ask me how I’m 
doing.  But, and lots of ways want to know that, oh, everything’s just fine.  You know, 
they just don’t want to know, don’t want to uh delve into it too much. 
 
Her siblings’ hesitancy to talk about the mutation has been difficult for Danielle.  She says:  
Um, my sisters don’t like to talk about it, don’t want to deal with it, the two sisters that 
have chose not to be tested.  And um that’s very difficult for me because I need to talk 
about this and that’s my way of coping. 
 
Yet Danielle still seemed to want to keep her siblings informed about BRCA and cancer risks.  
She adapted to her siblings’ hesitancy by choosing methods to inform them other than directly 
talking to them about it. 
And um, and I also am hesitant to keep you know, I don’t want to, you know, it’s a fine 
line and I don’t want to push my sisters away…I get a sense if I continue to push this, 
that it’s gonna really impact our relationship negatively and I don’t want to do that…I 
mean, it’s they know, they know what the risk is and they know what to do, they know 
who to contact.  Um, we are fortunate enough [in their region] to have a support 
group…you know I send the news letters and that kind of thing, let them know when the 
speakers are happening…I think that’s my work now instead of to keep bringing it up. 
 
A very similar family dynamic was present in Claire’s family.  In this family, Claire’s siblings 
were supportive around the time of her prophylactic mastectomy, but were very hesitant to bring 
up related topics at other times. 
We got together and nobody brought it up once.  Like it was so, and for me it was so 
weird because it was just so important to me at the time.  A couple times that happened.  I 
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just have heard, you know, about the family having the gene or something, and then we’d 
get together and we’d be talking about the weather, you know, it was like they, they 
didn’t want to bring it up, or didn’t know what, or just, I don’t know, or didn’t want me 
to bring it up.  So it felt very odd for me because to me, I did want to discuss it with them 
and they weren’t that interested. 
 
 In the M family, although several members were very open to each other about the 
mutation and cancer risk management, certain family members were not.  Like these other two 
families, some family members did not acknowledge the mutation or even Monica’s recent 
prophylactic mastectomy at family gatherings.  Monica thinks these relatives were in denial. 
 Interviewer: Do they talk about it at all at family gatherings? 
Monica:  Yeah, but not unless um, the genetic issue, not unless my dad um, or [aunt] 
who’s the one that sent out the letter, she brings it up.  I mean the other five per se that 
haven’t got tested or anything, it’s a nonissue.  I mean, that’s the way it presents.  Maybe 
in their private home, um, you know, there’s some other discussion that I’m not aware 
about, but it’s not discussed openly with the extended family.  No.  And it’s, my 
classification on the outside is a big fat denial. 
 
Monica also describes how her grandmother is a good example of one of these relatives. 
 Interviewer:  Has your grandmother said anything to you? 
Monica:  Um, this is so, I hate this, this is funny.  Now my grandmother is a very kind, 
very caring person, but the woman has serious denial issues.  So they come to see me, my 
grandma, my aunt who’s just been an absolute gem…just been such a support…  I was in 
the hospital [after her prophylactic mastectomy], and I had a really hard time...  And it’s 
funny, my uncle, the baby that’s 4 years older than me, um, who is, you know, my dad’s 
half brother, um, wanted to come to the hospital.  ‘Oh, I wanna come with you guys, I’m 
gonna get cleaned up and I’m gonna come visit Monica’ and my grandma, ‘No, that’s not 
appropriate.’  And my aunt was pissed, and said ‘What, Mom?’  And she said, ‘Oh no, 
no, no we’re just gonna run out there and take her some flowers and we’ll be back, we’ll 
let you know.’  And my uncle’s kind of caught off guard says, ‘But no, I wanna go see 
her.’  And my aunt who’s pissed at my grandma, and she’s not the kind of woman that 
gets angry and confrontive to people and said, ‘What cause he’s a guy, he can’t deal with 
it if it’s a woman’s issue?...Get your head out of the sand.  This is family, this is 
everyone’s issue.  It doesn’t matter, there’s no gender cap on this.’ 
 
Like in Danielle’s family, having different coping strategies in the family can be a source of 
conflict, as appears to occur between Monica’s grandmother, who would prefer not to talk 
directly about the mastectomy, and Monica’s aunt and uncle, who are more open to discussing it.  
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Later in Monica’s interview she revealed that during this visit to the hospital her grandmother 
gave her a greeting card that said ‘Happy Easter’ rather than something like ‘Get Well Soon’.  
Monica took this as another indicator of her grandmother’s denial about the cancer risks in the 
family. 
Interestingly, Monica’s father, Mike, feels that their extended family actually does talk 
about the mutation and cancer risk quite a bit.  He also provides a reason for why Monica might 
be particularly sensitive. 
And so um, my wife and I were um supporting my family and they do talk about it, they do 
discuss it, they’re not afraid or ashamed of it, and Monica is saying no.  But I think Monica 
is, she, she’s still processing a lot, um, you know she’s 28, and, and she’s had uh, the 
bilateral mastectomy and she’s not finished with her therapy and um, she has uh, um, she’s 
not happy with the way things are going because she has a lot of pain, and fatigue, she’s a 
little misshapen, and you know, so there’s a lot of questions out there.  So I think she’s a 
little bit on guard. 
 
Overall, the study data demonstrate that in families in which a BRCA mutation has been 
identified, there often exist individuals who would prefer to ignore it.  These people tend to make 
their feelings known by avoiding talk about the subject all together.  This can create conflict 
within the families, especially when other family members value open discussions.  Again, 
members of the same family may have different perceptions about how BRCA testing has 
affected the family dynamics. 
5.2.2.3 Open communication with family 
As indicated above, many families in the study included at least some members who 
value open communication about the BRCA mutation.  In most families these individuals did find 
some family members they felt they could be open with. 
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Open communication could be detrimental, as evidenced by an exchange between 
Danielle and one of her sisters, after Danielle tested positive for the mutation and her sister tested 
negative.  Danielle says: 
She felt this huge sense of relief and said things in the beginning that were inappropriate 
and very hurtful, like ‘I can look at my daughter in my, her eyes and know she’s OK.’  
You know, things like that, that uh, she didn’t mean. 
 
For the most part, however, open communication was perceived in a positive manner by 
the participants in the study.  For instance, Mary speaks about how happy she is that she can be 
open with her nuclear family, even when some of their more extended family members are 
reluctant to talk. 
I’ve, I choose not to let it bother me because I think you know, I’m the only one that 
really needs to worry about this, and my immediate family is clued in and we talk about it 
all the time.  Everyday we see each other, every time we’re on the phone we talk about it.  
And so um, I mean there’s other people that are going to be in denial about some of these 
issues. 
 
Often, participants whose extended family was resistant to discussion were very open 
about the topic with their own children.  For instance, Danielle realized that being open with her 
own young daughters about the mutation and about her own prophylactic mastectomy would 
prepare them to cope with the cancer risk they may face in adulthood. 
Danielle:  I have two beautiful daughters, 8 and 10. 
Interviewer:  And how are they doing with all of this? 
Danielle:  Well, they’re, it’s interesting, you know, [husband] and I have chosen to be, 
you know, pretty open about this.  They don’t understand the genetics and that’s an OK 
thing, although, you know we’ve talked about, they know the words and the gene and that 
I’m doing this to prevent getting cancer…It’s kind of healthy and uh, you know, they see 
me uh, they see my incisions, they’re seeing me you know, as it heals…and uh, in fact on 
the whole I think it’s been really positive and I don’t regret how we’ve dealt with it.  
They’ve come on the internet with me when we were looking at [breast] reconstruction 
and making decisions and decisions like, they’re, ‘oh look at this one, this one look really 
good, mom,’ and you know, ‘dad come see this one,’ so I think that’s pretty healthy, to 
deal with it that way.  And then like, they may walk this path…and I want them to be uh, 
you know, whatever they see that you know, if they know this isn’t the end of the world, 
this is one small part in the whole picture… 
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Open communication in the family can also occur between only certain members, for 
instance only between female BRCA mutation carriers, as in the M family.  This observation will 
be discussed thoroughly in section 5.2.3.2.  
5.2.2.4 No or few perceived changes, or did not mention it 
Although the majority of study participants mentioned that there was some change in the 
family discussions after BRCA testing, a few participants either did not mention or did not 
perceive much of a change in the discussions in their families or in fact in the family dynamics at 
all.   
5.2.3 Theme # 3:  Feeling more or less connected to family members 
The last major theme discussed here is that after BRCA testing in their family, some individuals 
felt more connected or less connected with certain family members. 
5.2.3.1 Feeling a special connection with fellow mutation carriers 
Certain study participants expressed that, after receiving their test result, they felt a sense 
of belonging or a special connection with other family members carrying the mutation.  For 
instance, Mary, who underwent predictive genetic testing in her mid 20s after several aunts, her 
father and her older sister had tested positive for the family mutation, says: 
And so we are, you know, mature and adult, and have been adults through most of the 
time [her aunts] have been sick, and so again, it’s always the topic of discussion and so I 
feel like an instant sense of belonging and so you know, again because it’s not a club I 
want to belong to but it almost made me feel very welcome, very like, well you know, at 
least I have this wonderful network. 
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In fact, this same participant felt so strongly about the connection with other family members 
that she actually felt relieved that she tested positive, so that she and her sister could go through 
the experience together. 
This is horrible of course, but I kind of feel like, in a really weird way I felt really, really 
relieved in a very bizarre way because I had it and my sister did too…  We’re so close…I 
almost felt like, ‘Well, of course I’ve got this because she’s got this and we do everything 
together.’  And so it was, was easy in a bizarre way to feel, ‘Well, I’m not alone and she’s 
not alone and this is just, it’s just worked out great.’ 
 
Later, she says: 
 
We’ve got an amazing bond in addition to all the other things, already being sisters and 
friends, we have this thing that’s brought us so much closer… 
 
Another participant, Naomi, who was the first to undergo testing in her extended family, spoke 
about how testing positive for a mutation made her feel more connected to some of her deceased 
family members. 
My 3rd uncle, Nathan, who was my favorite (and my mom’s favorite brother – no 
coincidence, I’m sure), I believe would’ve “gotten” it, maybe it even would’ve helped him 
(as it has me) make sense of his mother’s and sister’s deaths.  I even think about whether it 
might have helped his health – perhaps (and this is total conjecture) there was a twinge of 
pain in his stomach that he ignored, that he wouldn’t have if he’d known about the 
mutation.  So in that sense I have a sort of melancholy, belated sense of identifying with 
him. 
 
Thus, some individuals who discover they have a BRCA mutation can find themselves 
identifying more or having a special connection with certain family members, either living or 
deceased. 
5.2.3.2 Feeling left out if not sharing the family mutation 
This special connection can make others in the family feel isolated or like outcasts in 
their own families.  For instance, in this study relatives who were not at risk of the mutation, like 
in-laws, as well as the men in the family, who carry a substantially lower cancer risk than 
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women, often felt helpless or like an outsider in the family.  This was perceived by Elise, a 
member of the E family, when she said, “I think that my dad feels a little like my brother – left 
out kind of.”  This feeling was especially dramatic in the M family.  Here Mike talks about a 
family gathering in which a ‘clique’ of female mutation carriers made others feel left out. 
And right after that, we went to a family gathering because it was a baptism of my um, 
one of my youngest nieces, and all the um, BRCA2 uh, victims were in a, club, in a little 
clique talking.  And my wife and my, my, the sister who’s never had been tested felt 
ostracized.  And they admitted it, they felt like they were not included in this 
conversation.  They didn’t have anything to add, they didn’t have anything to uh talk 
about, they felt they couldn’t talk about it so much and they very much felt like they were 
not in the club.  And it was a really strange situation…That um may not be the best news, 
but to all in the, in the group together and they know certain things and they have certain 
feelings that nobody else is going to have.  Um, I wasn’t in that discussion only because 
they were talking about prophylactic mastectomies, and oophorectomies, and uh, things 
that weren’t going to relate to me so much.  Uh and so, but I mean it was like instant 
cancer club.  It was bizarre. 
 
The female family member mentioned here who hadn’t had a cancer diagnosis or genetic testing 
felt left out since her sisters had all had cancer and were mutation carriers.  In fact, one reason 
she had been reluctant to pursue BRCA testing was because she felt if it was confirmed that she 
didn’t carry the mutation, she would not feel comfortable with her sisters, or her sisters would be 
angry.  Finally, she did pursue testing, with the blessing of her sisters.  Members of the M family 
talk about this family member. 
Mary:  She said something like you know, ‘Sometimes I feel because you know a couple 
of the other girls have cancer, and I don’t, I feel like they have a closer bond than I have 
with them.  And so sometimes I feel left out,’ she said, ‘like when going through 
something they call each other and they don’t necessarily call me because they don’t 
think I can understand.’     
 
Mike:  So after I got my test results she went and did it.  Um, partly to, because I think 
she ostracized that demon, and when admitted that she was afraid that she would be 
negative, wouldn’t feel comfortable being not in the club. 
 
Thus, sharing the mutation and/or sharing the cancer experience associated with it could connect 
family members but could also isolate others in the family.   
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5.2.3.3 Feeling isolated or less connected if not receiving wanted family support 
For many testing positive for the mutation, family support played a significant role in 
whether they felt connected or isolated in their family.  Mary seems to have foreseen this when 
she wanted to test positive so that she could support her sister, Monica, who had already tested 
positive for the mutation. 
Mike:  And [Mary] would have felt terrible if she had tested negative because then she 
couldn’t be as uh, as supportive and understanding and sympathetic with her sister. 
 
Danielle provides another example, by describing the isolation and hurt she felt when she did not 
receive support from her family.  Danielle is the only one in her family who tested positive, other 
than an 80 year old uncle. 
Danielle:  I didn’t expect my friends to understand on the same level.  But I did expect my 
sisters to understand.  Either they didn’t.  Or they weren’t able to give me the support I 
needed.  I accept that and I stop looking for it.  But the hurt is still there on some level but 
not to the same intensity.  I try to accept them for who they are not what they can give.  
Truly, I don’t think that they have any idea. 
 
As Danielle articulates, it is hard to tell if this lack of support was because her sisters could 
not empathize with her since they had not tested positive or because they lacked the skills to 
support her at all.  In fact, sometimes, different coping mechanisms or management decisions 
were the reason some family members were not as supportive as others wanted.  For instance, 
Claire discusses that even though she and her sister both tested positive for the mutation, she felt 
less connected to her because her sister did not understand Claire’s decision to have a 
prophylactic mastectomy. 
There are two situations where I think family bonds have been affected more strongly.  
One is, um, with my sister who actually ironically tested positive as well, when she and I 
made different decisions about mastectomy there was a period of time where I felt a lack 
of connection.  I felt like she tried, was trying to be supportive to me, but honestly she 
wasn’t.  She didn’t understand why I was doing this, she thought I had gone too far.  She 
grieved the loss of my breasts for me, I think.  I mean, I did too, but, um, she thought it 
was quite draconian.  And so we kind of like, we lost touch at some point over this.  Um, 
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and I think maybe that’s kind of getting where we’re moving past that now, but there’s 
certainly a period where I felt quite you know, like I wasn’t interested in being very close 
to her because I didn’t feel a sincere support.    
 
Negative reactions of family members, as well as the tendency of certain family members 
to avoid discussing the topic all together, as outlined previously, can be perceived as a similar 
lack of support, having the potential to make other family members feel isolated.  
Naomi, the participant for whom testing positive made her feel more connected to some 
of her deceased relatives, also felt less connected to other relatives after testing.  She explains 
that this feeling was based on her prediction that they would have coped with knowledge of the 
mutation differently from her. 
I’ve never really identified with (or even known) my surviving cousins – going through 
testing, learning my status, becoming a part of the “world” of people who have a BRCA 
mutation makes me feel even more separate from them.  The two uncles that I never got 
along with, even though they are dead, I feel sort of similar about – like they would never 
have “gotten” this, or taken it seriously in any way, and this is just another example of how 
unlike them I am. 
 
Thus, this study provides several examples of when family coping strategies and support seem to 
make family members feel more or less connected to their relatives. 
5.2.3.4 Genetic counseling process as a catalyst for initiating new relationships with 
relatives 
For one participant, Evelyn, genetic testing served to not only change existing 
relationships but also served as a reason to kindle new relationships with relatives she never 
knew.  This participant did not know her biological father or any of his relatives before this 
process.  However, through researching her family health history to prepare for genetic 
counseling, she has met many relatives and has become friends with them, something she feels 
good about. 
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However, the up side is that I met many cousins I never knew about.  They all knew 
about me.  Several of us are becoming great friends.  We are the same ages, we look 
alike, we are having fun together.  So I have to think that my biological father is smiling 
down on us. 
 
Thus, this research shows that genetic testing has the potential to make individuals feel 
closer or more distant from certain relatives.  These effects can be due to a special connection 
felt by sharing the mutation, to the types of coping strategies used in the family and the 
associated support from family, and to the need to contact long-lost relatives. 
5.2.4 How are these three main themes connected? 
As is likely evident throughout the preceding sections, all three major themes are intricately 
connected to each other.  For instance, disclosing information as part of the role of an index case 
can incite or influence genetic discussions in the family.  In contrast, the types of genetic 
conversations in the family can impact the burden felt by the index case.  As well, the receptivity 
of family to discussions can cause individuals, including index cases, to feel more or less 
connected to each other.  Likewise, feeling a connection to or a separation from family after 
testing can influence the dynamics of relationships, having an effect on family discussions at 
large.  Thus, any change in one domain after genetic testing is likely to influence the others, 
having potential for dramatic change in family dynamics. 
5.2.5 Changes in family relationships over three years – first and second interviews 
There were very few changes in family relationships noted between the first and second 
interviews with each participant.  Danielle, who did not feel supported by her siblings, noted that 
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over the three years or so since the first interview she has come to adjust her expectations of her 
siblings.   
The second part of this for me wasn’t feeling left out from friends, but it was a feeling of 
being left out by my siblings…My sisters and brother really didn’t know how to support 
me.  I was consumed by this in the beginning and they didn’t know how, or emotionally 
could not support me in the way that I needed.  That hurt me deeply (and if I let myself, 
still does).  I’ve had to re-look at my expectations and realize that they could not give me 
what I needed. 
 
Otherwise, it was hard to tell how family relationships had changed over the years from the first 
to the second interview.  Future studies with the same cohort of participants could involve asking 
directed questions about their current family relationships, how they compare to what they were 
like years before, and if any changes were noted, to what do they attribute the change. 
5.2.6 Other themes identified in the analysis 
Other themes were also noted in the analysis but were not expanded upon in this paper.  Here 
they will be listed.  Firstly, some participants seemed to be motivated by the memory or legacy 
of their deceased family members who had cancer.  For instance, they often appreciated their 
own opportunities to have testing for a BRCA mutation and regretted that their deceased relatives 
did not have the same opportunities.  Participants also sometimes expressed a wish to ‘pay 
forward’ their own fortune for future generations of their families.  Another theme was that 
parents testing positive for the mutation often expressed guilt for passing on the mutation to their 
children.  Roles of family members other than the index case were also often altered by the news 
of a BRCA mutation, such as a younger sister doting on her older sister once the older sister 
tested positive and chose to have a mastectomy.  As well, individuals who tested positive for a 
mutation tended to take their other family member’s cancer diagnoses and surgeries more 
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personally, since they could very well be their own.  Family members also tended to hold back 
their emotions from others in their family, to protect themselves, to protect their family 
members, or to protect their family relationships in general. 
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6.0  DISCUSSION 
This study represents one of the few to investigate how testing positive for a BRCA mutation can 
influence relationships among family members.  To summarize the results briefly, some of the 
families illustrated that family dynamics were altered after testing, and the changes could often 
be perceived as either positive or negative.  Among the many themes identified in the analysis, 
three in particular were commonly reported and were the focus of this paper:  1. That the first in 
the family to have testing or seek genetic counseling takes on a special family role that can be 
difficult for them;  2. That discussions in the family, especially those associated with BRCA 
testing, often change after genetic testing; and  3. That individuals may feel more or less 
connected to certain family members after genetic testing has occurred in the family.  The study 
also demonstrates that these changes in family dynamics can depend on the family history of 
cancer, prior relationships among the family, emotional coping strategies of relatives, value 
placed on particular communication patterns, and sharing or not sharing the family’s BRCA 
mutation.   
As mentioned earlier, all of these effects of BRCA testing on the family, as well as the 
determinants of the effects, are related to one another and interconnected.  Therefore, we would 
expect that if BRCA testing impacts one aspect of a relationship between family members, a 
ripple effect may occur, influencing other aspects in some way.  
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Here the study’s findings are compared with previous work.  Attention is then focused on 
what health professionals might find useful for their practice based on the findings.  Finally, the 
limitations of the study as well as areas for future research are addressed. 
6.1 STUDY FINDINGS IN THE CONTEXT OF PREVIOUS WORK 
6.1.1 Theme # 1: New or changed family roles as the index case 
As outlined in the Background and Significance section, previous studies have shown that 
individuals often decide to undergo BRCA testing to provide information for their family, some 
even feeling that their family has a right to know this information (Hallowell, 1999; Tercyak et 
al., 2007; Phelps et al., 2007; Foster et al., 2004; Daly et al., 2001; Goelen et al., 1999; Foster et 
al., 2002; Hallowell et al., 2003; Green et al., 1997).  Thus, it was not surprising that index cases 
in the current study tended to feel an obligation or responsibility to inform their relatives of their 
BRCA mutation.  The burden they felt when disclosing the information to their families is also 
consistent with the findings of previous studies (Kenen et al., 2006; McGivern et al., 2004; 
d’Agincourt-Canning, 2001; Hallowell et al., 2005b; Costalas et al., 2003).  Importantly, the 
current study demonstrates that the special role of the family’s index case can be transferred to 
others in the family under certain circumstances, as one study participant assumed the obligation 
and burden of informing relatives of the mutation after her mother, the first in the family to have 
BRCA testing, passed away from cancer. 
For one participant, the new role she assumed as the first in her family to have testing 
involved acting as a role model for her younger siblings, both in explaining genetic information 
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as well as demonstrating how to cope emotionally with cancer and genetic testing.  As described, 
she felt somewhat pressured to fulfill this role.  In the literature, there are reports of tested 
individuals feeling burdened by the need to accurately explain the implications of their test 
results, especially when they themselves do not fully grasp the concepts (Kenen et al., 2006; 
DudokdeWit et al., 1997; Costalas et al., 2003).  However, to my knowledge, there have been no 
reports of individuals feeling burdened because they are pressured to model emotional coping for 
their family in the context of BRCA testing.  Importantly, as described above, one reason Elise 
felt pressured into this role was because, unlike the other index cases in the study, she had no 
known family history of cancer.  Thus, in her case, her new family role was possibly related to 
the details of her family history. 
The new role that index cases tend to take on after testing positive for a BRCA mutation 
may also be in part due to something special about index cases themselves.  One study in 
particular suggested that index cases think differently than their relatives (Loader et al., 2004).  
In this study individuals interested in genetic testing (i.e. index cases) had to recruit a family 
member to also undergo testing.  It was found that the index cases tended to perceive their 
emotional and physical health as worse than did their relatives, even when the index cases were 
healthy and their relatives had cancer.  As well, following genetic counseling and testing, breast 
cancer worry fell for most recruited relatives but remained steady for most index cases.  These 
trends suggest that those individuals who initiate a genetic consult and testing are more anxious 
about their health and are more preoccupied by breast cancer worry than are some of their 
relatives.  It is possible then that this psychological profile of typical index cases could at least 
partially explain the burden they feel after genetic testing.  For instance, perhaps their burden 
derives from predicting that their relatives will feel as anxious and worried as they do with the 
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news of the mutation, when in reality this may not actually be true.  Future study could further 
investigate the reasons index cases tend to feel burdened in their new family role. 
6.1.2 Theme # 2: Genetic testing affects discussions in the family 
As mentioned, several studies have commented on the types of discussions in families after 
BRCA testing, however few made them a primary focus.  The current study reveals that, for some 
families, genetic testing serves as a catalyst for conversations about cancer or for more general 
contact.  These conversations can improve a relationship if they are welcomed or can upset 
individuals if they are unwelcome.  Similarly, it is common in families for some members to be 
resistant to discussing cancer or genetic testing, and their reluctance can sometimes isolate or 
hurt the family members who want to talk about it.  Those wanting to talk however do tend to 
find some relatives to be open with, commonly their children, spouse, or biological relatives with 
whom they feel a special connection.  Open communication can be used to prepare family 
members like children for the cancer risk they may face in their future. 
 These results are reminiscent of a study in which Kenen et al. (2004) interviewed 
unaffected women with a family history of breast and/or ovarian cancer after attending a cancer 
genetics consult.  In contrast to the current study, these women had not had genetic testing, and 
were not aware of testing results for any of their relatives.  Despite this difference, the study by 
Kenen et al. (2004) identified a very similar range of family communication patterns as did the 
current study.  This would suggest that learning about the potential for a family BRCA mutation 
during a genetic counseling session might result in similar types of family communication as 
actually receiving the news of a BRCA mutation after testing is pursued.  Perhaps, in both 
situations, individuals in the family draw from the family scripts, coping mechanisms and 
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heuristics that they have established throughout their lifetimes.  Similar forms of communication 
have also been noted in families in which members are at risk for Huntington disease (HD), an 
inherited degenerative condition in which movement, cognition and psychiatric state are 
compromised later in life (Sobel and Cowan, 2003; Holt, 2006; Sobel and Cowan, 2000).    
6.1.3 Theme # 3: Feeling more or less connected to family members 
Many participants in the current study described that, after genetic testing, they or other relatives 
felt more or less connected to certain family members.  Sometimes a special connection arose 
from sharing the BRCA mutation with relatives.  This has been observed in a study by Duncan et 
al. (2008) for young people that had genetic testing for HD or familial adenomatous polyposis 
(FAP), another cancer predisposition syndrome.  In the current study, some family members who 
did not share the mutation felt left out or less connected to their family.  To my knowledge, this 
has not been found previously in BRCA families, however, it has been noted in individuals 
testing negative for the gene for HD (Sobel and Cowan, 2003; Sobel and Cowan, 2000).  
Notably, Sobel and Cowan (2003) described one individual who attempted suicide because her 
negative test result made her feel disconnected from her siblings, who were already displaying 
the signs of HD. 
The current study also establishes that individuals testing positive for a mutation may be 
at particular risk of feeling isolated in their family if their family members do not share their 
coping styles.  This has been seen several times before in BRCA families (Phelps et al., 2007; 
Speice et al., 2002) and in families with HD or FAP (Sobel and Cowan, 2000; Sobel and Cowan., 
2003; Duncan et al., 2008).  Specifically, the current study highlights that individuals who are 
the only ones in their family to test positive may be especially at risk of feeling isolated since 
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their family may not be able to empathize and provide the support needed.  However, the 
findings also suggest that individuals who share the mutation with close relatives may still feel 
isolated or disconnected if they cope differently or make different management decisions than 
these relatives. 
Lastly, for one participant, meeting distant relatives while researching her family cancer 
history was a very positive experience as it allowed her to feel more connected to her family as a 
whole.  However, as Carlsson and Nilbert (2007) point out in their study of families undergoing 
genetic testing for hereditary non-polyposis colorectal cancer (HNPCC), meeting long-lost 
relatives may not always be welcomed, and sometimes researching the family cancer history can 
reveal family secrets like the existence of step/half siblings and extramarital children.     
6.2 IMPLICATIONS FOR GENETICS PROFESSIONALS 
As evidenced by this study, genetic counselors and other genetics professionals might benefit 
from recognizing that genetic counseling or testing can have profound influences on their 
patients not only by helping their patients to clarify their risk of cancer but also by influencing 
their family lives. 
Firstly, it could benefit cancer genetics professionals to recognize the special role that 
index cases can have in their family.  This is critical especially since it is not uncommon for 
patients attending cancer genetics clinics to be the first in their families to pursue counseling and 
testing (Darcy Thull, personal communication).  Professionals can attempt to prepare their 
patients for this special role or provide anticipatory guidance before receiving their test results.  
Genetics professionals might also want to consider inquiring about staging or prognosis of sick 
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patients since this information could help predict whether the role of index case might shift to 
another relative, as seen once in this study after the index case passed away from cancer. 
Genetics professionals may find it helpful to be aware that women who are the first in 
their families to have cancer may feel pressured to act as a role model to their families.  Unlike 
those who have a strong family history of cancer, these individuals have not watched older 
family members be sick or die from cancer, they have not been exposed to stories about cancer in 
their families, and they have not grown up thinking they were at high risk for cancer.  Thus, they 
have no prior family experiences from which to model their own actions or emotions, and instead 
take on the responsibility of being a model for the rest of their family.  Discovering that they 
carry a BRCA mutation may intensify this pressure since it implicates that their close family 
members are very likely to need guidance at some point, after their own cancer diagnoses.  
Women in this situation are presenting more commonly to genetics clinics for testing, since in 
recent years it has been recognized that particular family structures, such as having few women 
in the family, can mask the presence of a BRCA mutation (Weitzel et al., 2007) and thus not 
everyone who has a BRCA mutation has a dramatic family history of cancer. 
Genetics professionals could consider preparing their patients for the types of reactions 
that their family members might have to testing information.  Counselors might review with the 
patient the relationships he or she has with each relative, as well as the coping skills each relative 
tends to use, in order to try to identify relationships that may result in conflict or emotional 
distance after testing.  Family or individual therapy may be a useful referral for some of these 
families.      
Importantly, in the families from which more than one member participated in this study, 
there were several examples of scenarios in which relatives had different perceptions about 
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family dynamics.  This was true even though the family members asserted that they had a very 
close relationship with each other.  Genetics professionals could draw upon this observation and 
offer to teach skills to families that would empower them to open up to each other, or they could 
provide a physical venue for family members to come together and discuss their feelings with 
one another.  Promoting such open communication might prevent feelings of isolation in the 
family and might make family members aware of the difficult new family roles that some family 
members assume after testing. 
In order to prepare genetics professionals for these types of interventions, training 
programs should consider how to address such psychosocial concerns.  Ideally, both the 
classroom and the clinical domains of their education programs could include relevant training.  
Eventually, the efficacy of genetics training and of the counseling interventions outlined above 
should be assessed in order to determine how well genetics professionals are addressing concerns 
about BRCA testing and the family. 
6.3 IMPLICATIONS FOR PRIMARY CARE PROVIDERS 
Recent marketing efforts to primary care providers (PCPs) by genetic testing laboratories have 
placed pressure on PCPs to order BRCA tests and interpret the results.  However, there is concern 
that PCPs in busy practices have neither the time nor the specialized training to address the 
psychosocial implications of BRCA testing, such as the potential for impact on family dynamics 
as described in this study.  Thus, PCPs might benefit from referring patients considering BRCA 
testing to genetic counseling services.  There, patients can participate in multiple appointments, 
each up to two hours in length, to discuss with a genetic counselor the potential for testing, a 
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service that most PCPs are not in the position to provide.  Effort could be directed toward 
educating PCPs of genetic counseling services and targeting them as a referral agent, underlining 
the potential for PCPs to save time by referring their patients to genetics.     
6.4 STUDY LIMITATIONS AND FUTURE RESEARCH 
6.4.1 Recruitment and selection bias 
One limitation to the study was that there may have been bias in the personality traits or the 
experience of the individuals who participated in the study, due to the nature of participant 
involvement in the research or to the recruitment method of the initial study.  The results of this 
study suggest that families in which a BRCA mutation is present typically consist of some 
members who want to talk about the mutation, cancer risk and management, and others who 
would prefer to avoid these discussions all together.  Since this study involved in-depth 
interviews, it might have attracted the individuals who were more willing to discuss their 
experience with BRCA testing.  Using the FORCE website to recruit for the study may have also 
selected for individuals who tended to be open or proactive about their cancer risk, since they 
may have been visiting the site to participate in the online support community or to review the 
extensive information featured on the site about risk management options.  Attempts were made 
to counter this bias by asking participants if they thought their family members would be 
interested in participating in the study.  However, if family relationships were already strained by 
BRCA testing, participants might be unwilling to ask their family members to participate.  Thus, 
this bias may be unavoidable in some cases, and participants should be asked to richly describe 
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interactions with their family members in order to gain the most accurate information as possible 
about their relationships with relatives that are unwilling to participate.  Future studies involving 
several members of the same family could be performed in order to better understand the 
differing viewpoints that seem to be occurring among family members, as described in the 
Results section. 
 As well, a limitation of the study was that all participants had tested positive for a BRCA 
mutation.  Further studies should address the experiences of individuals testing negative for a 
mutation, both in families in which a mutation had been identified as well as in families in which 
no prior family member had been found to have a mutation.  This would be useful in 
appreciating the full spectrum of experiences that members of tested families can have.  
6.4.2 Grounded theory and interview methodology 
The grounded theory and open-ended interview methodology used in the initial study promoted a 
rich description of the experience that the participants chose to focus on.  However, if family 
relationships after BRCA testing were not the focus of some participants, very little insight into 
the dynamics of their families could be gleaned from the secondary analysis.  For example, there 
were a few participants in the study that spoke almost exclusively about their experiences with 
management choices like surgeries as well as their involvement in community-based 
organizations.  When asked about if or how BRCA testing had influenced their relationships with 
their families, they would either deny that there was any influence or they would answer with a 
short statement only.  It is hard to discern whether they really did not perceive any change within 
their families or if they did perceive a change but didn’t want to talk about it.  In situations where 
there really were no or only minimal changes in family dynamics, a possible next question would 
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be why?  Unfortunately, the current study was not able to address this.  It would be useful if 
future studies could try to outline the profile of families whose dynamics are not seriously 
affected by genetic testing, so that genetics professionals could use this information to identify 
families at high risk for serious negative changes in family relationships, and try to minimize 
these upsetting effects. 
Another limitation in the interview process was that not all participants were asked in 
their second interview whether and how their relationships with their families had changed since 
the first interview.  Thus, from the current secondary data analysis, it is hard to describe any 
trends in how families might incorporate the knowledge of a mutation into the way they interact 
with each other in the long term.  Dr. Hamilton is planning on following the same cohort of 
participants for several more years.  In future interviews with them she could ask them to 
compare their current family relationships with what they were like years before.  The 
participants could then be asked to comment on any changes they noted.  Perhaps questions 
about the three main themes found in the current study could be used as prompts for the 
participants to recall how family dynamics may have changed over time. 
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